Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Autoimmune Disorders

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 623 articles:
HTML format



Single Articles


    January 2020
  1. LI Z, Rotival M, Patin E, Michel F, et al
    Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
    PLoS One. 2020;15:e0225289.
    PubMed     Abstract available


  2. MATSUOKA N, Fujita Y, Temmoku J, Furuya MY, et al
    Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
    PLoS One. 2020;15:e0227069.
    PubMed     Abstract available


  3. JANG S, Kim JH, Choi SY, Park SJ, et al
    Application of computerized 3D-CT texture analysis of pancreas for the assessment of patients with diabetes.
    PLoS One. 2020;15:e0227492.
    PubMed     Abstract available


  4. PLAZINSKA MT, Sawicka-Gutaj N, Czarnywojtek A, Wolinski K, et al
    Radioiodine therapy and Graves' disease - Myths and reality.
    PLoS One. 2020;15:e0226495.
    PubMed     Abstract available


  5. OGAWA-AKIYAMA A, Sugiyama H, Kitagawa M, Tanaka K, et al
    Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
    PLoS One. 2020;15:e0228337.
    PubMed     Abstract available


  6. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    PubMed     Abstract available


  7. AHMED CM, Ildefonso CJ, Johnson HM, Lewin AS, et al
    A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis.
    PLoS One. 2020;15:e0227524.
    PubMed     Abstract available


  8. CHEWCHARAT A, Chewcharat P, Rutirapong A, Papatheodorou S, et al
    The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0228315.
    PubMed     Abstract available


  9. PELLEGRINO M, Traversi G, Arena A, Cappa M, et al
    Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients.
    PLoS One. 2020;15:e0228296.
    PubMed     Abstract available


  10. PENG YH, Lin YS, Chen CH, Tsai KY, et al
    Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
    PLoS One. 2020;15:e0226997.
    PubMed     Abstract available


  11. HOSONUMA M, Yajima N, Takahashi R, Yanai R, et al
    Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity.
    PLoS One. 2020;15:e0227022.
    PubMed     Abstract available


  12. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed     Abstract available


  13. GOLDMAN MD, Dwyer L, Coleman R, Sohn MW, et al
    Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
    PLoS One. 2020;15:e0228617.
    PubMed     Abstract available


  14. HJORTH M, Dandu N, Mellergard J
    Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    PLoS One. 2020;15:e0228380.
    PubMed     Abstract available


  15. GRANER M, Pointon T, Manton S, Green M, et al
    Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
    PLoS One. 2020;15:e0228883.
    PubMed     Abstract available


  16. ZWINGLI G, Yerly J, Mivelaz Y, Stoppa-Vaucher S, et al
    Non-invasive assessment of coronary endothelial function in children and adolescents with type 1 diabetes mellitus using isometric handgrip exercise-MRI: A feasibility study.
    PLoS One. 2020;15:e0228569.
    PubMed     Abstract available


  17. GIOVANNETTI AM, Pietrolongo E, Borreani C, Giordano A, et al
    Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.
    PLoS One. 2020;15:e0228587.
    PubMed     Abstract available


  18. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed     Abstract available


  19. AUNGSUMART S, Apiwattanakul M
    Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    PLoS One. 2020;15:e0229028.
    PubMed     Abstract available


  20. YALACHKOV Y, Uhlmann V, Bergmann J, Soydas D, et al
    Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance.
    PLoS One. 2020;15:e0228679.
    PubMed     Abstract available


  21. BRANT EJ, Rietman EA, Klement GL, Cavaglia M, et al
    Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks.
    PLoS One. 2020;15:e0226883.
    PubMed     Abstract available


    January 2019
  22. OCANA GJ, Sims EK, Watkins RA, Ragg S, et al
    Analysis of serum Hsp90 as a potential biomarker of beta cell autoimmunity in type 1 diabetes.
    PLoS One. 2019;14:e0208456.
    PubMed     Abstract available


  23. KOBELT G, Teich V, Cavalcanti M, Canzonieri AM, et al
    Burden and cost of multiple sclerosis in Brazil.
    PLoS One. 2019;14:e0208837.
    PubMed     Abstract available


  24. ROONEY NJ, Guest CM, Swanson LCM, Morant SV, et al
    How effective are trained dogs at alerting their owners to changes in blood glycaemic levels?: Variations in performance of glycaemia alert dogs.
    PLoS One. 2019;14:e0210092.
    PubMed     Abstract available


  25. FRAHM N, Hecker M, Zettl UK
    Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.
    PLoS One. 2019;14:e0211120.
    PubMed     Abstract available


  26. PELLEGRINO M, Crino A, Rosado MM, Fierabracci A, et al
    Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients.
    PLoS One. 2019;14:e0210839.
    PubMed     Abstract available


  27. WORMSBECKER AE, Johnson C, Bourns L, Harris T, et al
    Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
    PLoS One. 2019;14:e0210833.
    PubMed     Abstract available


  28. LI YJ, Wu HH, Liu SH, Tu KH, et al
    Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis.
    PLoS One. 2019;14:e0210633.
    PubMed     Abstract available


  29. DUQUETTE P, Yeung M, Mouallif S, Nakhaipour HR, et al
    A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies.
    PLoS One. 2019;14:e0210417.
    PubMed     Abstract available


  30. BRAFFETT BH, Rice MM, Young HA, Lachin JM, et al
    Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes.
    PLoS One. 2019;14:e0210367.
    PubMed     Abstract available


  31. LI X, He L, Wang J, Wang M, et al
    Illness uncertainty, social support, and coping mode in hospitalized patients with systemic lupus erythematosus in a hospital in Shaanxi, China.
    PLoS One. 2019;14:e0211313.
    PubMed     Abstract available


  32. LIAO D, Ma L, Liu J, Fu P, et al
    Cigarette smoking as a risk factor for diabetic nephropathy: A systematic review and meta-analysis of prospective cohort studies.
    PLoS One. 2019;14:e0210213.
    PubMed     Abstract available


  33. PEARSALL EA, Cheng R, Matsuzaki S, Zhou K, et al
    Neuroprotective effects of PPARalpha in retinopathy of type 1 diabetes.
    PLoS One. 2019;14:e0208399.
    PubMed     Abstract available


  34. YEOW TP, Aun ES, Hor CP, Lim SL, et al
    Challenges in the classification and management of Asian youth-onset diabetes mellitus- lessons learned from a single centre study.
    PLoS One. 2019;14:e0211210.
    PubMed     Abstract available


  35. KITAMURA M, Obata Y, Ota Y, Muta K, et al
    Significance of subepithelial deposits in patients diagnosed with IgA nephropathy.
    PLoS One. 2019;14:e0211812.
    PubMed     Abstract available


  36. SCHMIDT P, Kempin R, Langner S, Beule A, et al
    Association of anthropometric markers with globe position: A population-based MRI study.
    PLoS One. 2019;14:e0211817.
    PubMed     Abstract available


  37. HESSELS AC, van der Hoeven JH, Sanders JSF, Brouwer E, et al
    Leg muscle strength is reduced and is associated with physical quality of life in Antineutrophil cytoplasmic antibody-associated vasculitis.
    PLoS One. 2019;14:e0211895.
    PubMed     Abstract available


  38. MAIXNEROVA D, Ling C, Hall S, Reily C, et al
    Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    PLoS One. 2019;14:e0212254.
    PubMed     Abstract available


  39. LANG SN, Germerodt S, Glock C, Skerka C, et al
    Molecular crypsis by pathogenic fungi using human factor H. A numerical model.
    PLoS One. 2019;14:e0212187.
    PubMed     Abstract available


  40. CARTER KL, Treurnicht A, Davis KL, Kumar RB, et al
    A novel platform for isotype-specific testing of autoantibodies.
    PLoS One. 2019;14:e0211596.
    PubMed     Abstract available


  41. DE OLIVEIRA AR, da Silva FS, Bortolin RH, Marques DEDS, et al
    Effect of photobiomodulation and exercise on early remodeling of the Achilles tendon in streptozotocin-induced diabetic rats.
    PLoS One. 2019;14:e0211643.
    PubMed     Abstract available


  42. BIGAUT K, Achard S, Hemmert C, Baloglu S, et al
    Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).
    PLoS One. 2019;14:e0211465.
    PubMed     Abstract available


  43. KALTSONOUDIS E, Pelechas E, Papoudou-Bai A, Markatseli TE, et al
    The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital.
    PLoS One. 2019;14:e0210845.
    PubMed     Abstract available


  44. LINDHOLM E, Londahl M, Fagher K, Apelqvist J, et al
    Strong association between vibration perception thresholds at low frequencies (4 and 8 Hz), neuropathic symptoms and diabetic foot ulcers.
    PLoS One. 2019;14:e0212921.
    PubMed     Abstract available


  45. DUCHATEAU L, Martin-Aguilar L, Lleixa C, Cortese A, et al
    Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy.
    PLoS One. 2019;14:e0212647.
    PubMed     Abstract available


  46. VAN LEEUWEN N, Walgaard C, van Doorn PA, Jacobs BC, et al
    Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barre syndrome.
    PLoS One. 2019;14:e0211404.
    PubMed     Abstract available


  47. LEE S, Salapa HE, Levin MC
    Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
    PLoS One. 2019;14:e0212357.
    PubMed     Abstract available


  48. VAN DER DONK LJ, Fleer J, Sanderman R, Emmelkamp PMG, et al
    Is type of depressive symptoms associated with patient-perceived need for professional psychological care in depressed individuals with diabetes?
    PLoS One. 2019;14:e0212304.
    PubMed     Abstract available


  49. MIRANDA S, Billoir P, Damian L, Thiebaut PA, et al
    Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction.
    PLoS One. 2019;14:e0212614.
    PubMed     Abstract available


  50. PARK DW, Lee YJ, Chang W, Park JH, et al
    Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease.
    PLoS One. 2019;14:e0212771.
    PubMed     Abstract available


  51. PARODIS I, Ding H, Zickert A, Cosson G, et al
    Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
    PLoS One. 2019;14:e0212068.
    PubMed     Abstract available


  52. SHAPSON-COE A, Valeiras B, Wall C, Rada C, et al
    Aicardi-Goutieres Syndrome associated mutations of RNase H2B impair its interaction with ZMYM3 and the CoREST histone-modifying complex.
    PLoS One. 2019;14:e0213553.
    PubMed     Abstract available


  53. WEI F, Xu H, Yan C, Rong C, et al
    Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China.
    PLoS One. 2019;14:e0213063.
    PubMed     Abstract available


  54. GIROLAMO F, Errede M, Longo G, Annese T, et al
    Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    PLoS One. 2019;14:e0213508.
    PubMed     Abstract available


  55. EIDEN S, Beck C, Venhoff N, Elsheikh S, et al
    High-resolution contrast-enhanced vessel wall imaging in patients with suspected cerebral vasculitis: Prospective comparison of whole-brain 3D T1 SPACE versus 2D T1 black blood MRI at 3 Tesla.
    PLoS One. 2019;14:e0213514.
    PubMed     Abstract available


  56. ANDERSON K, Carey B, Martin A, Roark C, et al
    Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association.
    PLoS One. 2019;14:e0213179.
    PubMed     Abstract available


  57. PATRICK S, Connick P
    Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.
    PLoS One. 2019;14:e0197943.
    PubMed     Abstract available


  58. AZAMI M, YektaKooshali MH, Shohani M, Khorshidi A, et al
    Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0214738.
    PubMed     Abstract available


  59. KAIHAN AB, Yasuda Y, Imaizumi T, Inagaki K, et al
    Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.
    PLoS One. 2019;14:e0214414.
    PubMed     Abstract available


  60. ATKINSON MA, Joo S, Sule S
    Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.
    PLoS One. 2019;14:e0214248.
    PubMed     Abstract available


  61. BAGCHI S, Lingaiah R, Mani K, Barwad A, et al
    Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    PLoS One. 2019;14:e0214256.
    PubMed     Abstract available


  62. LEE SU, Li CF, Mortales CL, Pawling J, et al
    Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.
    PLoS One. 2019;14:e0214253.
    PubMed     Abstract available


  63. VAZQUEZ-MATEO C, Collins J, Goldberg SJ, Lawson M, et al
    Combining anti-IL-7Ralpha antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
    PLoS One. 2019;14:e0214379.
    PubMed     Abstract available


  64. KAGEYAMA T, Furuta S, Ikeda K, Kagami SI, et al
    Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases.
    PLoS One. 2019;14:e0214324.
    PubMed     Abstract available


  65. LEE J, An JN, Hwang JH, Lee H, et al
    p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients.
    PLoS One. 2019;14:e0213981.
    PubMed     Abstract available


  66. SHIRIN A, Della Rossa F, Klickstein I, Russell J, et al
    Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon.
    PLoS One. 2019;14:e0213665.
    PubMed     Abstract available


  67. LARDINOIS OM, Deterding LJ, Hess JJ, Poulton CJ, et al
    Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
    PLoS One. 2019;14:e0213215.
    PubMed     Abstract available


  68. NEATE SL, Taylor KL, Jelinek GA, De Livera AM, et al
    Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification.
    PLoS One. 2019;14:e0212422.
    PubMed     Abstract available


  69. GAVILAN-CARRERA B, Garcia da Silva J, Vargas-Hitos JA, Sabio JM, et al
    Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity.
    PLoS One. 2019;14:e0212436.
    PubMed     Abstract available


  70. ABDULLAH A, Maged M, Hairul-Islam M I, Osama I A, et al
    Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
    PLoS One. 2019;14:e0215981.
    PubMed     Abstract available


  71. KONG Y, Rastogi D, Seoighe C, Greally JM, et al
    Insights from deconvolution of cell subtype proportions enhance the interpretation of functional genomic data.
    PLoS One. 2019;14:e0215987.
    PubMed     Abstract available


  72. LI S, Cao Y, Li L, Zhang H, et al
    Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.
    PLoS One. 2019;14:e0214857.
    PubMed     Abstract available


  73. HOGESTOL EA, Nygaard GO, Alnaes D, Beyer MK, et al
    Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis.
    PLoS One. 2019;14:e0210375.
    PubMed     Abstract available


  74. SCHIERLOH U, Wilinska ME, Pit-Ten Cate IM, Baumann P, et al
    Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial.
    PLoS One. 2019;14:e0212013.
    PubMed     Abstract available


  75. TEMPLETON N, Kivell B, McCaughey-Chapman A, Connor B, et al
    Clozapine administration enhanced functional recovery after cuprizone demyelination.
    PLoS One. 2019;14:e0216113.
    PubMed     Abstract available


  76. PEREZ DEL PALOMAR A, Cegonino J, Montolio A, Orduna E, et al
    Swept source optical coherence tomography to early detect multiple sclerosis disease. The use of machine learning techniques.
    PLoS One. 2019;14:e0216410.
    PubMed     Abstract available


  77. TAKASHI Y, Ishizu M, Mori H, Miyashita K, et al
    Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes.
    PLoS One. 2019;14:e0216416.
    PubMed     Abstract available


  78. BIKBOV MM, Fayzrakhmanov RR, Kazakbaeva GM, Zainullin RM, et al
    Prevalence, awareness and control of diabetes in Russia: The Ural Eye and Medical Study on adults aged 40+ years.
    PLoS One. 2019;14:e0215636.
    PubMed     Abstract available


  79. O'ROURKE JA, Ravichandran C, Howe YJ, Mullett JE, et al
    Accuracy of self-reported history of autoimmune disease: A pilot study.
    PLoS One. 2019;14:e0216526.
    PubMed     Abstract available


  80. LACKNER J, Weiss M, Muller-Graf C, Greiner M, et al
    The disease burden associated with Campylobacter spp. in Germany, 2014.
    PLoS One. 2019;14:e0216867.
    PubMed     Abstract available


  81. ALOWAYESH MS, Ahmed SF, Al-Hashel J, Alroughani R, et al
    Economic burden of multiple sclerosis on Kuwait health care system.
    PLoS One. 2019;14:e0216646.
    PubMed     Abstract available


  82. DE SANTIAGO L, Sanchez Morla EM, Ortiz M, Lopez E, et al
    A computer-aided diagnosis of multiple sclerosis based on mfVEP recordings.
    PLoS One. 2019;14:e0214662.
    PubMed     Abstract available


  83. BEDRI SK, Nilsson OB, Fink K, Manberg A, et al
    Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.
    PLoS One. 2019;14:e0217208.
    PubMed     Abstract available


  84. JIMENEZ VERA E, Chew YV, Nicholson L, Burns H, et al
    Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients.
    PLoS One. 2019;14:e0217163.
    PubMed     Abstract available


  85. SHIN DH, Baek IC, Kim HJ, Choi EJ, et al
    HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease.
    PLoS One. 2019;14:e0216941.
    PubMed     Abstract available


  86. THORNTON SNIDER J, Sullivan J, van Eijndhoven E, Hansen MK, et al
    Lifetime benefits of early detection and treatment of diabetic kidney disease.
    PLoS One. 2019;14:e0217487.
    PubMed     Abstract available


  87. EVDOSHENKO E, Stepanova A, Shumilina M, Davydovskaya M, et al
    Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
    PLoS One. 2019;14:e0217303.
    PubMed     Abstract available


  88. ZHANG Y, Welzig CM, Haburcak M, Wang B, et al
    Targeted disruption of glycogen synthase kinase-3beta in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice.
    PLoS One. 2019;14:e0215213.
    PubMed     Abstract available


  89. ZHANG W, Rho JH, Roehrl MW, Roehrl MH, et al
    A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins.
    PLoS One. 2019;14:e0219018.
    PubMed     Abstract available


  90. NAVARRO QUIROZ E, Navarro Quiroz R, Pacheco Lugo L, Aroca Martinez G, et al
    Integrated analysis of microRNA regulation and its interaction with mechanisms of epigenetic regulation in the etiology of systemic lupus erythematosus.
    PLoS One. 2019;14:e0218116.
    PubMed     Abstract available


  91. ROSNER B, Roman-Urrestarazu A
    Health-related quality of life in paediatric patients with Type 1 diabetes mellitus using insulin infusion systems. A systematic review and meta-analysis.
    PLoS One. 2019;14:e0217655.
    PubMed     Abstract available


  92. OHLSSON S, Holm L, Hansson C, Ohlsson SM, et al
    Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
    PLoS One. 2019;14:e0218272.
    PubMed     Abstract available


  93. MARRIE RA, O'Mahony J, Maxwell CJ, Ling V, et al
    High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.
    PLoS One. 2019;14:e0218215.
    PubMed     Abstract available


  94. UEKI M, Fujihara J, Kimura-Kataoka K, Yamada K, et al
    Low genetic heterogeneity of copy number variations (CNVs) in the genes encoding the human deoxyribonucleases 1-like 3 and II potentially relevant to autoimmunity.
    PLoS One. 2019;14:e0215479.
    PubMed     Abstract available


  95. RESALAT N, El Youssef J, Tyler N, Castle J, et al
    A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model.
    PLoS One. 2019;14:e0217301.
    PubMed     Abstract available


  96. RO LS, Yang CC, Lyu RK, Lin KP, et al
    A prospective, observational study on conversion of clinically isolated syndrome to multiple sclerosis during 4-year period (MS NEO study) in Taiwan.
    PLoS One. 2019;14:e0202453.
    PubMed     Abstract available


  97. MORISHITA M, Sada KE, Matsumoto Y, Hayashi K, et al
    Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    PLoS One. 2019;14:e0218705.
    PubMed     Abstract available


  98. PETRETTO A, Bruschi M, Pratesi F, Croia C, et al
    Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis.
    PLoS One. 2019;14:e0218946.
    PubMed     Abstract available


  99. LANDTBLOM AM, Guala D, Martin C, Olsson-Hau S, et al
    RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif.
    PLoS One. 2019;14:e0218453.
    PubMed     Abstract available


  100. OEVERHAUS M, Copei A, Mattheis S, Ringelstein A, et al
    Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy.
    PLoS One. 2019;14:e0218701.
    PubMed     Abstract available


  101. MANUWALD U, Schoffer O, Hegewald J, Grosse J, et al
    Ketoacidosis at onset of type 1 diabetes in children up to 14 years of age and the changes over a period of 18 years in Saxony, Eastern-Germany: A population based register study.
    PLoS One. 2019;14:e0218807.
    PubMed     Abstract available


  102. FELLOWS MAXWELL K, Wahls T, Browne RW, Rubenstein L, et al
    Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study.
    PLoS One. 2019;14:e0218075.
    PubMed     Abstract available


  103. GRIMALDI AE, De Giglio L, Haggiag S, Bianco A, et al
    The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
    PLoS One. 2019;14:e0219670.
    PubMed     Abstract available


  104. THALER MA, Bietenbeck A, Steigerwald U, Buttner T, et al
    Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs.
    PLoS One. 2019;14:e0220033.
    PubMed     Abstract available


  105. UCHI SH, Yanai R, Kobayashi M, Hatano M, et al
    Dendritic cells mediate the anti-inflammatory action of omega-3 long-chain polyunsaturated fatty acids in experimental autoimmune uveitis.
    PLoS One. 2019;14:e0219405.
    PubMed     Abstract available


  106. LOPEZ-MORAL M, Lazaro-Martinez JL, Garcia-Morales E, Garcia-Alvarez Y, et al
    Clinical efficacy of therapeutic footwear with a rigid rocker sole in the prevention of recurrence in patients with diabetes mellitus and diabetic polineuropathy: A randomized clinical trial.
    PLoS One. 2019;14:e0219537.
    PubMed     Abstract available


  107. KYVSGAARD N, Mikkelsen TS, Thastum M, Christensen AE, et al
    Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
    PLoS One. 2019;14:e0219539.
    PubMed     Abstract available


  108. KURANO M, Yatomi Y
    Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice.
    PLoS One. 2019;14:e0219403.
    PubMed     Abstract available


  109. KIM DH, Kim DW, Park JY, Lee YJ, et al
    Ultrasound detection of incidental diffuse parotid disease: A single-center study.
    PLoS One. 2019;14:e0219308.
    PubMed     Abstract available


  110. ZHENG X, Zhang Y, Yue P, Liu L, et al
    Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
    PLoS One. 2019;14:e0217523.
    PubMed     Abstract available


  111. MAHMUD M, Pinnschmidt HO, Reinhard L, Harendza S, et al
    Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
    PLoS One. 2019;14:e0221293.
    PubMed     Abstract available


  112. HAREL Y, Kalron A, Menascu S, Magalashvili D, et al
    Cognitive function in multiple sclerosis: A long-term look on the bright side.
    PLoS One. 2019;14:e0221784.
    PubMed     Abstract available


  113. CUI J, Yan W, Xie H, Xu S, et al
    Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.
    PLoS One. 2019;14:e0221793.
    PubMed     Abstract available


  114. CURRIE CJ, Berni ER, Berni TR, Jenkins-Jones S, et al
    Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status.
    PLoS One. 2019;14:e0221044.
    PubMed     Abstract available


  115. ISMAILOVA K, Poudel P, Parlesak A, Frederiksen P, et al
    Vitamin D in early life and later risk of multiple sclerosis-A systematic review, meta-analysis.
    PLoS One. 2019;14:e0221645.
    PubMed     Abstract available


  116. YANG WL, Bose B, Zhang L, Mcstea M, et al
    Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    PLoS One. 2019;14:e0221531.
    PubMed     Abstract available


  117. JANG SY, Chae MK, Lee JH, Lee EJ, et al
    MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.
    PLoS One. 2019;14:e0221077.
    PubMed     Abstract available


  118. ZHANG G, Bogdanova N, Gao T, Sheikh KA, et al
    Elimination of activating Fcgamma receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease.
    PLoS One. 2019;14:e0220250.
    PubMed     Abstract available


  119. SUGIMOTO M, Kondo M, Kamimoto Y, Ikeda T, et al
    Changes in VEGF-related factors are associated with presence of inflammatory factors in carbohydrate metabolism disorders during pregnancy.
    PLoS One. 2019;14:e0220650.
    PubMed     Abstract available


  120. STANGOU M, Marinaki S, Papachristou E, Kolovou K, et al
    Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
    PLoS One. 2019;14:e0217116.
    PubMed     Abstract available


  121. OBRISCA B, Stefan G, Gherghiceanu M, Mandache E, et al
    "Associated" or "Secondary" IgA nephropathy? An outcome analysis.
    PLoS One. 2019;14:e0221014.
    PubMed     Abstract available


  122. WALTEROS DM, Soares J, Styczynski AR, Abrams JY, et al
    Long-term outcomes of Guillain-Barre syndrome possibly associated with Zika virus infection.
    PLoS One. 2019;14:e0220049.
    PubMed     Abstract available


  123. URRUTIA I, Martinez R, Rica I, Martinez de LaPiscina I, et al
    Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?
    PLoS One. 2019;14:e0220634.
    PubMed     Abstract available


  124. LAVIA C, Couturier A, Erginay A, Dupas B, et al
    Reduced vessel density in the superficial and deep plexuses in diabetic retinopathy is associated with structural changes in corresponding retinal layers.
    PLoS One. 2019;14:e0219164.
    PubMed     Abstract available


  125. NASER AY, Wong ICK, Whittlesea C, Alwafi H, et al
    Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study.
    PLoS One. 2019;14:e0222275.
    PubMed     Abstract available


  126. AMATO MP, Prestipino E, Bellinvia A, Niccolai C, et al
    Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
    PLoS One. 2019;14:e0222929.
    PubMed     Abstract available


  127. TAKEI Y, Takahashi S, Nakasatomi M, Sakairi T, et al
    Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.
    PLoS One. 2019;14:e0223703.
    PubMed     Abstract available


  128. JONGEN PJ, van Mastrigt GA, Heerings M, Visser LH, et al
    Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
    PLoS One. 2019;14:e0223482.
    PubMed     Abstract available


  129. KISHI K, Kaji N, Kurosawa T, Aikiyo S, et al
    Hyperglycemia in the early stages of type 1 diabetes accelerates gastric emptying through increased networks of interstitial cells of Cajal.
    PLoS One. 2019;14:e0222961.
    PubMed     Abstract available


  130. SHAHARIR SS, Mohamed Said MS, Mohd R, Abdul Cader R, et al
    Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia.
    PLoS One. 2019;14:e0222343.
    PubMed     Abstract available


  131. MOCCIA M, Tajani A, Acampora R, Signoriello E, et al
    Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.
    PLoS One. 2019;14:e0222012.
    PubMed     Abstract available


  132. GOOCH A, Zhang P, Hu Z, Loy Son N, et al
    Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776).
    PLoS One. 2019;14:e0218688.
    PubMed     Abstract available


  133. SHI J, Wu X, Chen Y
    Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis.
    PLoS One. 2019;14:e0222288.
    PubMed     Abstract available


  134. BUDA N, Masiak A, Zdrojewski Z
    Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement.
    PLoS One. 2019;14:e0222189.
    PubMed     Abstract available


  135. LUCIANO-JARAMILLO J, Sandoval-Garcia F, Vazquez-Del Mercado M, Gutierrez-Mercado YK, et al
    Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice.
    PLoS One. 2019;14:e0217190.
    PubMed     Abstract available


  136. LLAURADO G, Cano A, Albert L, Ballesta S, et al
    Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM.
    PLoS One. 2019;14:e0220206.
    PubMed     Abstract available


  137. TASHIRO R, Niizuma K, Khor SS, Tokunaga K, et al
    Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.
    PLoS One. 2019;14:e0220858.
    PubMed     Abstract available


  138. EHLING R, Bsteh G, Muehlbacher A, Hermann K, et al
    Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.
    PLoS One. 2019;14:e0220613.
    PubMed     Abstract available


  139. GAJAMANGE S, Shelton A, Clough M, White O, et al
    Functional correlates of cognitive dysfunction in clinically isolated syndromes.
    PLoS One. 2019;14:e0219590.
    PubMed     Abstract available


  140. VAZQUEZ-MARRUFO M, Galvao-Carmona A, Caballero-Diaz R, Borges M, et al
    Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
    PLoS One. 2019;14:e0219594.
    PubMed     Abstract available


  141. ZHANG L, Li Y, Lin X, Jia C, et al
    Liquid Chromatography/Mass Spectrometry based serum metabolomics study on recurrent abortion women with antiphospholipid syndrome.
    PLoS One. 2019;14:e0225463.
    PubMed     Abstract available


  142. BOQUETE L, Lopez-Guillen E, Vilades E, Miguel-Jimenez JM, et al
    Diagnostic ability of multifocal electroretinogram in early multiple sclerosis using a new signal analysis method.
    PLoS One. 2019;14:e0224500.
    PubMed     Abstract available


  143. SELVARAJA M, Abdullah M, Arip M, Chin VK, et al
    Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
    PLoS One. 2019;14:e0224707.
    PubMed     Abstract available


  144. STEINL DC, Xu L, Ochoa-Espinosa A, Punjabi M, et al
    Non-invasive contrast enhanced ultrasound molecular imaging of inflammation in autoimmune myocarditis for prediction of left ventricular fibrosis and remodeling.
    PLoS One. 2019;14:e0224377.
    PubMed     Abstract available


  145. KAPICA-TOPCZEWSKA K, Tarasiuk J, Collin F, Brola W, et al
    The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
    PLoS One. 2019;14:e0223863.
    PubMed     Abstract available


  146. HOLOHAN DR, Van Gool F, Bluestone JA
    Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
    PLoS One. 2019;14:e0217728.
    PubMed     Abstract available


  147. RYU J, Ryu H, Kim S, Chin HJ, et al
    Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy.
    PLoS One. 2019;14:e0224024.
    PubMed     Abstract available


  148. FISHER SA, Rahimzadeh M, Brierley C, Gration B, et al
    The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review.
    PLoS One. 2019;14:e0222313.
    PubMed     Abstract available


  149. ONDREJKOVA M, Jackuliak P, Martinka E, Mokan M, et al
    Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study.
    PLoS One. 2019;14:e0223788.
    PubMed     Abstract available


  150. ELSO CM, Scott NA, Mariana L, Masterman EI, et al
    Replacing murine insulin 1 with human insulin protects NOD mice from diabetes.
    PLoS One. 2019;14:e0225021.
    PubMed     Abstract available


  151. LI Y, Higgs RE, Hoffman RW, Dow ER, et al
    A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.
    PLoS One. 2019;14:e0225651.
    PubMed     Abstract available


  152. MAYO M, Chepulis L, Paul RG
    Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning.
    PLoS One. 2019;14:e0225613.
    PubMed     Abstract available


  153. JIANG N, Li M, Zhang M, Xu J, et al
    Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus.
    PLoS One. 2019;14:e0225516.
    PubMed     Abstract available


  154. CHEN HH, Lin CH, Chen DY, Chao WC, et al
    Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study.
    PLoS One. 2019;14:e0222860.
    PubMed     Abstract available


  155. GROENER JB, Valkanou A, Kender Z, Pfeiffenberger J, et al
    Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
    PLoS One. 2019;14:e0222771.
    PubMed     Abstract available


  156. HAMMOND CL, Roztocil E, Phipps RP, Feldon SE, et al
    Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.
    PLoS One. 2019;14:e0222779.
    PubMed     Abstract available


  157. LIN SD, Butler JE, Boswell-Ruys CL, Hoang P, et al
    The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience.
    PLoS One. 2019;14:e0222731.
    PubMed     Abstract available


  158. BURKILL S, Vattulainen P, Geissbuehler Y, Sabido Espin M, et al
    The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
    PLoS One. 2019;14:e0227120.
    PubMed     Abstract available


  159. PAN X, Kaminga AC, Wen SW, Acheampong K, et al
    Omentin-1 in diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226292.
    PubMed     Abstract available


  160. CORTINI A, Bembich S, Marson L, Cocco E, et al
    Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.
    PLoS One. 2019;14:e0226162.
    PubMed     Abstract available


  161. HAMMAD SM, Hardin JR, Wilson DA, Twal WO, et al
    Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    PLoS One. 2019;14:e0224496.
    PubMed     Abstract available


  162. CECCARELLI F, Pirone C, Mina C, Mascolo A, et al
    Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    PLoS One. 2019;14:e0224437.
    PubMed     Abstract available


  163. POSTIGO-ALONSO B, Galvao-Carmona A, Conde-Gavilan C, Jover A, et al
    The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls.
    PLoS One. 2019;14:e0226775.
    PubMed     Abstract available


  164. MELIS M, Littera R, Cocco E, Frau J, et al
    Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
    PLoS One. 2019;14:e0226615.
    PubMed     Abstract available


  165. EHLING R, Amprosi M, Kremmel B, Bsteh G, et al
    Second language learning induces grey matter volume increase in people with multiple sclerosis.
    PLoS One. 2019;14:e0226525.
    PubMed     Abstract available


    January 2018
  166. PLACZEK WJ, Yanagawa H, Makita Y, Renfrow MB, et al
    Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    PLoS One. 2018;13:e0190967.
    PubMed     Abstract available


  167. OZTURK MC, Xu Q, Cinar A
    Agent-based modeling of the interaction between CD8+ T cells and Beta cells in type 1 diabetes.
    PLoS One. 2018;13:e0190349.
    PubMed     Abstract available


  168. AGAH E, Zardoui A, Saghazadeh A, Ahmadi M, et al
    Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0190252.
    PubMed     Abstract available


  169. AKERMAN L, Casas R, Ludvigsson J, Tavira B, et al
    Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
    PLoS One. 2018;13:e0191067.
    PubMed     Abstract available


  170. WANG C, Klistorner A, Ly L, Barnett MH, et al
    White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques.
    PLoS One. 2018;13:e0191131.
    PubMed     Abstract available


  171. LAVTAR P, Rudolf G, Maver A, Hodzic A, et al
    Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis.
    PLoS One. 2018;13:e0190601.
    PubMed     Abstract available


  172. MEMON AB, Javed A, Caon C, Srivastawa S, et al
    Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.
    PLoS One. 2018;13:e0190425.
    PubMed     Abstract available


  173. HENSCHEL AM, Cabrera SM, Kaldunski ML, Jia S, et al
    Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and beta-cell chemokine expression associated with autoimmune diabetes susceptibility.
    PLoS One. 2018;13:e0190351.
    PubMed     Abstract available


  174. DAHDAL S, Devetzis V, Chalikias G, Tziakas D, et al
    Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
    PLoS One. 2018;13:e0188695.
    PubMed     Abstract available


  175. SHIN S, Jung CH, Choi JY, Kwon HW, et al
    Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
    PLoS One. 2018;13:e0191421.
    PubMed     Abstract available


  176. BEGGS CB, Giaquinta A, Veroux M, De Marco E, et al
    Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis.
    PLoS One. 2018;13:e0191534.
    PubMed     Abstract available


  177. BONNET-SERRANO F, Diedisheim M, Mallone R, Larger E, et al
    Decreased alpha-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository.
    PLoS One. 2018;13:e0191528.
    PubMed     Abstract available


  178. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility.
    PLoS One. 2018;13:e0190043.
    PubMed     Abstract available


  179. HASSANI A, Corboy JR, Al-Salam S, Khan G, et al
    Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
    PLoS One. 2018;13:e0192109.
    PubMed     Abstract available


  180. LIMIRIO PHJO, da Rocha Junior HA, Morais RB, Hiraki KRN, et al
    Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats.
    PLoS One. 2018;13:e0191694.
    PubMed     Abstract available


  181. SIMEONOVIC CJ, Popp SK, Starrs LM, Brown DJ, et al
    Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans.
    PLoS One. 2018;13:e0191360.
    PubMed     Abstract available


  182. CALOCER F, Dejardin O, Droulon K, Launoy G, et al
    Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.
    PLoS One. 2018;13:e0191646.
    PubMed     Abstract available


  183. MUKHOPADHYAY N, Noble JA, Govil M, Marazita ML, et al
    Identifying genetic risk loci for diabetic complications and showing evidence for heterogeneity of type 1 diabetes based on complications risk.
    PLoS One. 2018;13:e0192696.
    PubMed     Abstract available


  184. ISLAM Z, Jahan I, Ahammad RU, Shahnaij M, et al
    FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barre syndrome.
    PLoS One. 2018;13:e0192703.
    PubMed     Abstract available


  185. DE FLON P, Soderstrom L, Laurell K, Dring A, et al
    Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.
    PLoS One. 2018;13:e0192516.
    PubMed     Abstract available


  186. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    PubMed     Abstract available


  187. DENNISON L, Brown M, Kirby S, Galea I, et al
    Do people with multiple sclerosis want to know their prognosis? A UK nationwide study.
    PLoS One. 2018;13:e0193407.
    PubMed     Abstract available


  188. POTTGEN J, Rose A, van de Vis W, Engelbrecht J, et al
    Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: A scoping review.
    PLoS One. 2018;13:e0193381.
    PubMed     Abstract available


  189. WALLUKAT G, Pruss H, Muller J, Schimke I, et al
    Functional autoantibodies in patients with different forms of dementia.
    PLoS One. 2018;13:e0192778.
    PubMed     Abstract available


  190. RAHIMI F, Rasekh HR, Abbasian E, Peiravian F, et al
    Patient preferences for Interferon-beta in Iran: A discrete choice experiment.
    PLoS One. 2018;13:e0193090.
    PubMed     Abstract available


  191. BAGNATO F, Hametner S, Boyd E, Endmayr V, et al
    Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.
    PLoS One. 2018;13:e0193839.
    PubMed     Abstract available


  192. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
    Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    PLoS One. 2018;13:e0193960.
    PubMed     Abstract available


  193. STOUSTRUP P, Iversen CK, Kristensen KD, Resnick CM, et al
    Assessment of dentofacial growth deviation in juvenile idiopathic arthritis: Reliability and validity of three-dimensional morphometric measures.
    PLoS One. 2018;13:e0194177.
    PubMed     Abstract available


  194. PARK KH, Waters P, Woodhall M, Lang B, et al
    Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    PLoS One. 2018;13:e0193723.
    PubMed     Abstract available


  195. KHAN A, Kamran S, Ponirakis G, Akhtar N, et al
    Peripheral neuropathy in patients with multiple sclerosis.
    PLoS One. 2018;13:e0193270.
    PubMed     Abstract available


  196. DRABORG AH, Rasmussen NS, Larsen JL, Jorgensen CS, et al
    Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
    PLoS One. 2018;13:e0193244.
    PubMed     Abstract available


  197. GERASIMOU P, Nicolaidou V, Skordis N, Picolos M, et al
    Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.
    PLoS One. 2018;13:e0193684.
    PubMed     Abstract available


  198. CUI J, Yan W, Xu S, Wang Q, et al
    Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    PLoS One. 2018;13:e0193171.
    PubMed     Abstract available


  199. NARDIN C, Latarche C, Soudant M, Dahan C, et al
    Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.
    PLoS One. 2018;13:e0194115.
    PubMed     Abstract available


  200. HASLACHER H, Fallmann H, Waldhausl C, Hartmann E, et al
    Type 1 diabetes care: Improvement by standardization in a diabetes rehabilitation clinic. An observational report.
    PLoS One. 2018;13:e0194135.
    PubMed     Abstract available


  201. MARGIOTTA DPE, Basta F, Dolcini G, Batani V, et al
    Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus.
    PLoS One. 2018;13:e0193728.
    PubMed     Abstract available


  202. PONSONBY AL, Pezic A, Cameron FJ, Rodda C, et al
    Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices.
    PLoS One. 2018;13:e0193992.
    PubMed     Abstract available


  203. KOZIARSKA D, Krol J, Nocon D, Kubaszewski P, et al
    Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.
    PLoS One. 2018;13:e0194117.
    PubMed     Abstract available


  204. HEMMINGER J, Arole V, Ayoub I, Brodsky SV, et al
    Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis.
    PLoS One. 2018;13:e0193274.
    PubMed     Abstract available


  205. TURTON JL, Raab R, Rooney KB
    Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review.
    PLoS One. 2018;13:e0194987.
    PubMed     Abstract available


  206. HOLM LJ, Haupt-Jorgensen M, Larsen J, Giacobini JD, et al
    L-serine supplementation lowers diabetes incidence and improves blood glucose homeostasis in NOD mice.
    PLoS One. 2018;13:e0194414.
    PubMed     Abstract available


  207. ANDROULIDAKI A, Wachsmuth L, Polykratis A, Pasparakis M, et al
    Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes.
    PLoS One. 2018;13:e0194048.
    PubMed     Abstract available


  208. KODA T, Namba A, Nakatsuji Y, Niino M, et al
    Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
    PLoS One. 2018;13:e0193986.
    PubMed     Abstract available


  209. GARNIER AS, Duveau A, Demiselle J, Croue A, et al
    Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    PLoS One. 2018;13:e0196101.
    PubMed     Abstract available


  210. MORILLAS-DE-LAGUNO P, Vargas-Hitos JA, Rosales-Castillo A, Saez-Uran LM, et al
    Association of objectively measured physical activity and sedentary time with arterial stiffness in women with systemic lupus erythematosus with mild disease activity.
    PLoS One. 2018;13:e0196111.
    PubMed     Abstract available


  211. KLISTORNER A, Wang C, Yiannikas C, Parratt J, et al
    Diffusivity in the core of chronic multiple sclerosis lesions.
    PLoS One. 2018;13:e0194142.
    PubMed     Abstract available


  212. FIGUEIREDO-BRAGA M, Cornaby C, Bernardes M, Figueiredo M, et al
    Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease.
    PLoS One. 2018;13:e0195579.
    PubMed     Abstract available


  213. MIZUGUCHI Y, Morimoto S, Kimura S, Takano N, et al
    Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
    PLoS One. 2018;13:e0195464.
    PubMed     Abstract available


  214. NOVAKOVA L, Axelsson M, Malmestrom C, Imberg H, et al
    Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
    PLoS One. 2018;13:e0194828.
    PubMed     Abstract available


  215. MOSER O, Eckstein ML, McCarthy O, Deere R, et al
    Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes.
    PLoS One. 2018;13:e0194750.
    PubMed     Abstract available


  216. TAYLOR MEADOWS KR, Steinberg MW, Clemons B, Stokes ME, et al
    Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus.
    PLoS One. 2018;13:e0193236.
    PubMed     Abstract available


  217. ABDOLLAHPOUR I, Nedjat S, Mansournia MA, Schuster T, et al
    Estimation of the marginal effect of regular drug use on multiple sclerosis in the Iranian population.
    PLoS One. 2018;13:e0196244.
    PubMed     Abstract available


  218. UECHI E, Okada M, Fushimi K
    Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database.
    PLoS One. 2018;13:e0196009.
    PubMed     Abstract available


  219. ISING E, Dahlin LB, Elding Larsson H
    Impaired vibrotactile sense in children and adolescents with type 1 diabetes - Signs of peripheral neuropathy.
    PLoS One. 2018;13:e0196243.
    PubMed     Abstract available


  220. LARANJEIRA FO, de Andrade KRC, Figueiredo ACMG, Silva EN, et al
    Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0194801.
    PubMed     Abstract available


  221. HESSELS AC, Rutgers A, Sanders JSF, Stegeman CA, et al
    Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.
    PLoS One. 2018;13:e0195524.
    PubMed     Abstract available


  222. KAWAI Y, Masutani K, Torisu K, Katafuchi R, et al
    Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    PLoS One. 2018;13:e0196655.
    PubMed     Abstract available


  223. NWOSU BU, Zhang B, Ayyoub SS, Choi S, et al
    Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.
    PLoS One. 2018;13:e0196912.
    PubMed     Abstract available


  224. FERNANDEZ O, Izquierdo G, Fernandez V, Leyva L, et al
    Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
    PLoS One. 2018;13:e0195891.
    PubMed     Abstract available


  225. KRAAL LJN, Nijland ML, Germar KL, Baeten DLP, et al
    Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.
    PLoS One. 2018;13:e0197219.
    PubMed     Abstract available


  226. WITHER JE, Prokopec SD, Noamani B, Chang NH, et al
    Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.
    PLoS One. 2018;13:e0196117.
    PubMed     Abstract available


  227. HANAOKA H, Iida H, Kiyokawa T, Takakuwa Y, et al
    Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
    PLoS One. 2018;13:e0196172.
    PubMed     Abstract available


  228. CECCARELLI F, Perricone C, Pirone C, Massaro L, et al
    Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
    PLoS One. 2018;13:e0196103.
    PubMed     Abstract available


  229. LIN Y, Liu L, Sheng Y, Shen C, et al
    A catalog of potential putative functional variants in psoriasis genome-wide association regions.
    PLoS One. 2018;13:e0196635.
    PubMed     Abstract available


  230. STORM FA, Nair KPS, Clarke AJ, Van der Meulen JM, et al
    Free-living and laboratory gait characteristics in patients with multiple sclerosis.
    PLoS One. 2018;13:e0196463.
    PubMed     Abstract available


  231. DE SANTIAGO L, Sanchez-Morla E, Blanco R, Miguel JM, et al
    Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLoS One. 2018;13:e0194964.
    PubMed     Abstract available


  232. CIURLEO R, Bonanno L, De Salvo S, Romeo L, et al
    Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.
    PLoS One. 2018;13:e0196006.
    PubMed     Abstract available


  233. SANCHEZ-DALMAU B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, et al
    Predictors of vision impairment in Multiple Sclerosis.
    PLoS One. 2018;13:e0195856.
    PubMed     Abstract available


  234. MASUDA K, Tanabe K, Ujike H, Hinamoto N, et al
    Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    PLoS One. 2018;13:e0195779.
    PubMed     Abstract available


  235. DESHAYES S, Aouba A, Khoy K, Mariotte D, et al
    Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis.
    PLoS One. 2018;13:e0195680.
    PubMed     Abstract available


  236. WUERFEL E, Weddige A, Hagmayer Y, Jacob R, et al
    Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    PLoS One. 2018;13:e0194873.
    PubMed     Abstract available


  237. TAHVILI S, Torngren M, Holmberg D, Leanderson T, et al
    Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.
    PLoS One. 2018;13:e0196598.
    PubMed     Abstract available


  238. MIKI A, Ricordi C, Sakuma Y, Yamamoto T, et al
    Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
    PLoS One. 2018;13:e0196570.
    PubMed     Abstract available


  239. DUARTE-GARCIA A, Romero-Diaz J, Juarez S, Cicero-Casarrubias A, et al
    Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.
    PLoS One. 2018;13:e0196487.
    PubMed     Abstract available


  240. SCARR D, Lovblom LE, Cardinez N, Orszag A, et al
    Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    PLoS One. 2018;13:e0196647.
    PubMed     Abstract available


  241. CHROBOK NL, Bol JGJM, Jongenelen CA, Breve JJP, et al
    Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    PLoS One. 2018;13:e0196433.
    PubMed     Abstract available


  242. PACKIALAKSHMI B, Zhou X
    Experimental autoimmune encephalomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex.
    PLoS One. 2018;13:e0196277.
    PubMed     Abstract available


  243. MENDOZA-PINTO C, Rojas-Villarraga A, Molano-Gonzalez N, Jimenez-Herrera EA, et al
    Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.
    PLoS One. 2018;13:e0196113.
    PubMed     Abstract available


  244. MARCK CH, De Livera AM, Brown CR, Neate SL, et al
    Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up.
    PLoS One. 2018;13:e0197759.
    PubMed     Abstract available


  245. SCOTTI B, Disanto G, Sacco R, Guigli M, et al
    Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland.
    PLoS One. 2018;13:e0197415.
    PubMed     Abstract available


  246. YAMADA K, Zuka M, Ito K, Mizuguchi K, et al
    LatY136F knock-in mouse model for human IgG4-related disease.
    PLoS One. 2018;13:e0198417.
    PubMed     Abstract available


  247. WEIS CA, Aban IB, Cutter G, Kaminski HJ, et al
    Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.
    PLoS One. 2018;13:e0197435.
    PubMed     Abstract available


  248. KUWABARA Y, Katayama A, Kurihara S, Orimo H, et al
    Immunoproteomic identification of anti-C9 autoimmune antibody in patients with seronegative obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198472.
    PubMed     Abstract available


  249. ZHANG J, Liang Y, Ai Y, Li X, et al
    Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis.
    PLoS One. 2018;13:e0198504.
    PubMed     Abstract available


  250. DEPRE F, Aboud N, Mayer B, Salama A, et al
    Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
    PLoS One. 2018;13:e0198184.
    PubMed     Abstract available


  251. PARKER HARP CR, Archambault AS, Sim J, Shlomchik MJ, et al
    B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis.
    PLoS One. 2018;13:e0199694.
    PubMed     Abstract available


  252. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Abstract available


  253. WILLERS C, Iderberg H, Axelsen M, Dahlstrom T, et al
    Sociodemographic determinants and health outcome variation in individuals with type 1 diabetes mellitus: A register-based study.
    PLoS One. 2018;13:e0199170.
    PubMed     Abstract available


  254. LANATA CM, Nititham J, Taylor KE, Chung SA, et al
    Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients.
    PLoS One. 2018;13:e0199003.
    PubMed     Abstract available


  255. HAIDER MZ, Rasoul MA, Al-Mahdi M, Al-Kandari H, et al
    Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs.
    PLoS One. 2018;13:e0198652.
    PubMed     Abstract available


  256. BESSER REJ, Ludvigsson J, Hindmarsh PC, Cole TJ, et al
    Exploring C-peptide loss in type 1 diabetes using growth curve analysis.
    PLoS One. 2018;13:e0199635.
    PubMed     Abstract available


  257. HOZUMI H, Oyama Y, Yasui H, Suzuki Y, et al
    Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
    PLoS One. 2018;13:e0199659.
    PubMed     Abstract available


  258. LIANG D, Shao H, Born WK, O'Brien RL, et al
    High level expression of A2ARs is required for the enhancing function, but not for the inhibiting function, of gammadelta T cells in the autoimmune responses of EAU.
    PLoS One. 2018;13:e0199601.
    PubMed     Abstract available


  259. HACHICHA H, Mahfoudh N, Fourati H, Elloumi N, et al
    HLA Class III: A susceptibility region to systemic lupus erythematosus in Tunisian population.
    PLoS One. 2018;13:e0198549.
    PubMed     Abstract available


  260. GIOVANNETTI AM, Borreani C, Bianchi E, Giordano A, et al
    Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.
    PLoS One. 2018;13:e0200532.
    PubMed     Abstract available


  261. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Abstract available


  262. KARUPPAGOUNDER V, Bajpai A, Meng S, Arumugam S, et al
    Small molecule disruption of G protein betagamma subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
    PLoS One. 2018;13:e0200697.
    PubMed     Abstract available


  263. ADUSUMILLI G, Lancia S, Levasseur VA, Amblee V, et al
    Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    PLoS One. 2018;13:e0198178.
    PubMed     Abstract available


  264. KERVINEN MH, Lehto S, Helve J, Gronhagen-Riska C, et al
    Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation.
    PLoS One. 2018;13:e0201478.
    PubMed     Abstract available


  265. CUMMINGS M, Arumanayagam ACS, Zhao P, Kannanganat S, et al
    Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0200752.
    PubMed     Abstract available


  266. CASANA-GRANELL S, Lacomba-Trejo L, Valero-Moreno S, Prado-Gasco V, et al
    A brief version of the Pediatric Inventory for Parents (PIP) in Spanish population: Stress of main family carers of chronic paediatric patients.
    PLoS One. 2018;13:e0201390.
    PubMed     Abstract available


  267. SAIRANEN E, Lappalainen P, Hiltunen A
    Psychological inflexibility explains distress in parents whose children have chronic conditions.
    PLoS One. 2018;13:e0201155.
    PubMed     Abstract available


  268. ZHERNAKOVA DV, Kliver S, Cherkasov N, Tamazian G, et al
    Analytical "bake-off" of whole genome sequencing quality for the Genome Russia project using a small cohort for autoimmune hepatitis.
    PLoS One. 2018;13:e0200423.
    PubMed     Abstract available


  269. VIEIRA A, Vergoni B, Courtney M, Druelle N, et al
    Neurog3 misexpression unravels mouse pancreatic ductal cell plasticity.
    PLoS One. 2018;13:e0201536.
    PubMed     Abstract available


  270. KANG Y, Schlyer D, Kaunzner UW, Kuceyeski A, et al
    Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
    PLoS One. 2018;13:e0201289.
    PubMed     Abstract available


  271. MARTIN NA, Nawrocki A, Molnar V, Elkjaer ML, et al
    Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.
    PLoS One. 2018;13:e0202530.
    PubMed     Abstract available


  272. MOHN J, Igland J, Zoffmann V, Peyrot M, et al
    Factors explaining variation in self-esteem among persons with type 1 diabetes and elevated HbA1c.
    PLoS One. 2018;13:e0201006.
    PubMed     Abstract available


  273. LABAN S, Suwandi JS, van Unen V, Pool J, et al
    Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus.
    PLoS One. 2018;13:e0200818.
    PubMed     Abstract available


  274. NACKA-ALEKSIC M, Stojanovic M, Pilipovic I, Stojic-Vukanic Z, et al
    Strain differences in thymic atrophy in rats immunized for EAE correlate with the clinical outcome of immunization.
    PLoS One. 2018;13:e0201848.
    PubMed     Abstract available


  275. POPESCU DC, Huang H, Singhal NK, Shriver L, et al
    Vitamin K enhances the production of brain sulfatides during remyelination.
    PLoS One. 2018;13:e0203057.
    PubMed     Abstract available


  276. CHAWLA S, Kister I, Sinnecker T, Wuerfel J, et al
    Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging.
    PLoS One. 2018;13:e0202918.
    PubMed     Abstract available


  277. GONZALEZ-QUINTIAL R, Nguyen A, Kono DH, Oldstone MBA, et al
    Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition.
    PLoS One. 2018;13:e0203118.
    PubMed     Abstract available


  278. AGARWAL A, Hall RP 3rd, Banez LL, Cardones AR, et al
    Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
    PLoS One. 2018;13:e0198074.
    PubMed     Abstract available


  279. MALDONADO M, Buendia-Roldan I, Vicens-Zygmunt V, Planas L, et al
    Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
    PLoS One. 2018;13:e0203779.
    PubMed     Abstract available


  280. SCHENKEIN HA, Thomas RR
    Anticardiolipin (aCL) in sera from periodontitis subjects activate Toll-like receptor 4 (TLR4).
    PLoS One. 2018;13:e0203494.
    PubMed     Abstract available


  281. SIOOFY-KHOJINE AB, Oikarinen S, Honkanen H, Huhtala H, et al
    Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes.
    PLoS One. 2018;13:e0201959.
    PubMed     Abstract available


  282. BURKARD T, Trendelenburg M, Daikeler T, Hess C, et al
    The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.
    PLoS One. 2018;13:e0202105.
    PubMed     Abstract available


  283. PEJU M, Deroux A, Pelloux H, Bouillet L, et al
    Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation.
    PLoS One. 2018;13:e0204468.
    PubMed     Abstract available


  284. KRISTENSEN LJ, Birkebaek NH, Mose AH, Berg Jensen M, et al
    Multi-informant path models of the influence of psychosocial and treatment-related variables on adherence and metabolic control in adolescents with type 1 diabetes mellitus.
    PLoS One. 2018;13:e0204176.
    PubMed     Abstract available


  285. MOKHTARZADEH KHANGHAHI A, Satarian L, Deng W, Baharvand H, et al
    In vivo conversion of astrocytes into oligodendrocyte lineage cells with transcription factor Sox10; Promise for myelin repair in multiple sclerosis.
    PLoS One. 2018;13:e0203785.
    PubMed     Abstract available


  286. GRACIA F, Larreategui M, Rodriguez G, Benzadon A, et al
    Costs of multiple sclerosis in Panama from societal, patient perspectives and health-related quality of life.
    PLoS One. 2018;13:e0204681.
    PubMed     Abstract available


  287. TAKAHASHI A, Moriya K, Ohira H, Arinaga-Hino T, et al
    Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
    PLoS One. 2018;13:e0204772.
    PubMed     Abstract available


  288. KALKOWSKI L, Malysz-Cymborska I, Golubczyk D, Janowski M, et al
    MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine.
    PLoS One. 2018;13:e0204650.
    PubMed     Abstract available


  289. UGARTE-BERZAL E, Berghmans N, Boon L, Martens E, et al
    Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0197944.
    PubMed     Abstract available


  290. SCHEIDLER AM, Kinnett-Hopkins D, Learmonth YC, Motl R, et al
    Targeted ballet program mitigates ataxia and improves balance in females with mild-to-moderate multiple sclerosis.
    PLoS One. 2018;13:e0205382.
    PubMed     Abstract available


  291. LASO-GARCIA F, Ramos-Cejudo J, Carrillo-Salinas FJ, Otero-Ortega L, et al
    Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis.
    PLoS One. 2018;13:e0202590.
    PubMed     Abstract available


  292. SVOLGAARD O, Andersen KW, Bauer C, Madsen KH, et al
    Cerebellar and premotor activity during a non-fatiguing grip task reflects motor fatigue in relapsing-remitting multiple sclerosis.
    PLoS One. 2018;13:e0201162.
    PubMed     Abstract available


  293. RHEE RL, Holweg CTJ, Wong K, Cuthbertson D, et al
    Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis.
    PLoS One. 2018;13:e0205768.
    PubMed     Abstract available


  294. SENGUPTA M, Wang BD, Lee NH, Marx A, et al
    MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.
    PLoS One. 2018;13:e0205464.
    PubMed     Abstract available


  295. CHOI JY, Chung JE, Park JH, Cho YS, et al
    Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study.
    PLoS One. 2018;13:e0204573.
    PubMed     Abstract available


  296. GARAU M, Cabrera J, Ottati G, Caorsi H, et al
    Temporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014.
    PLoS One. 2018;13:e0206637.
    PubMed     Abstract available


  297. NOCITI V, Santoro M, Quaranta D, Losavio FA, et al
    BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    PLoS One. 2018;13:e0206140.
    PubMed     Abstract available


  298. DIVINO V, Mallick R, DeKoven M, Krishnarajah G, et al
    The economic burden of CIDP in the United States: A case-control study.
    PLoS One. 2018;13:e0206205.
    PubMed     Abstract available


  299. MARTINEZ VALENZUELA L, Draibe J, Quero Ramos M, Fulladosa Oliveras X, et al
    Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis.
    PLoS One. 2018;13:e0205982.
    PubMed     Abstract available


  300. PENG Y
    B cell responses to apoptotic cells in MFG-E8-/- mice.
    PLoS One. 2018;13:e0205172.
    PubMed     Abstract available


  301. BARBOSA FB, Simioni M, Wiezel CEV, Torres FR, et al
    Copy number variation in the susceptibility to systemic lupus erythematosus.
    PLoS One. 2018;13:e0206683.
    PubMed     Abstract available


  302. CHU R, Kim G, Tauhid S, Khalid F, et al
    Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    PLoS One. 2018;13:e0206939.
    PubMed     Abstract available


  303. JEONG A, Min JH, Kang YK, Kim J, et al
    Factors associated with quality of life of people with Myasthenia Gravis.
    PLoS One. 2018;13:e0206754.
    PubMed     Abstract available


  304. KOHN JR, Hilliard ME, Lyons SK, Fox KA, et al
    Identifying and addressing gaps in reproductive health education for adolescent girls with type 1 diabetes.
    PLoS One. 2018;13:e0206102.
    PubMed     Abstract available


  305. WADA Y, Matsumoto K, Suzuki T, Saito T, et al
    Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    PLoS One. 2018;13:e0206865.
    PubMed     Abstract available


  306. RHEAD B, Brorson IS, Berge T, Adams C, et al
    Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
    PLoS One. 2018;13:e0206511.
    PubMed     Abstract available


  307. SULLIVAN CA, Cacicedo JM, Rajendran I, Steenkamp DW, et al
    Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study.
    PLoS One. 2018;13:e0207065.
    PubMed     Abstract available


  308. MAIA DINIZ I, Guerra AA Junior, Lovato Pires de Lemos L, Souza KM, et al
    The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.
    PLoS One. 2018;13:e0199446.
    PubMed     Abstract available


  309. PAWLITZKI M, Sweeney-Reed CM, Meuth SG, Reinhold D, et al
    CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
    PLoS One. 2018;13:e0207726.
    PubMed     Abstract available


  310. AUDIA S, Bach B, Samson M, Lakomy D, et al
    Venous thromboembolic events during warm autoimmune hemolytic anemia.
    PLoS One. 2018;13:e0207218.
    PubMed     Abstract available


  311. GIORDANO A, Liethmann K, Kopke S, Poettgen J, et al
    Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.
    PLoS One. 2018;13:e0208004.
    PubMed     Abstract available


  312. BHANDAGE AK, Jin Z, Korol SV, Tafreshiha AS, et al
    Expression of calcium release-activated and voltage-gated calcium channels genes in peripheral blood mononuclear cells is altered in pregnancy and in type 1 diabetes.
    PLoS One. 2018;13:e0208981.
    PubMed     Abstract available


  313. ADU MD, Malabu UH, Malau-Aduli AEO, Malau-Aduli BS, et al
    Users' preferences and design recommendations to promote engagements with mobile apps for diabetes self-management: Multi-national perspectives.
    PLoS One. 2018;13:e0208942.
    PubMed     Abstract available


  314. GUARDIA-OLMOS J, Gudayol-Ferre E, Gallardo-Moreno GB, Martinez-Ricart M, et al
    Complex systems representing effective connectivity in patients with Type One diabetes mellitus.
    PLoS One. 2018;13:e0208247.
    PubMed     Abstract available


  315. PABALAN N, Tiongco RE, Pandac JK, Paragas NA, et al
    Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.
    PLoS One. 2018;13:e0208905.
    PubMed     Abstract available


  316. KOSKIMAKI F, Bernard J, Yong J, Arndt N, et al
    Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
    PLoS One. 2018;13:e0209326.
    PubMed     Abstract available


    January 2017
  317. CHANNANATH AM, Elkum N, Al-Abdulrazzaq D, Tuomilehto J, et al
    Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.
    PLoS One. 2017;12:e0175728.
    PubMed     Abstract available


  318. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Abstract available


  319. DE MACEDO MSFC, Costa KM, da Silva Filho M
    Voice disorder in systemic lupus erythematosus.
    PLoS One. 2017;12:e0175893.
    PubMed     Abstract available


  320. ZHANG JJ, Yu GZ, Zheng ZH, Liu YF, et al
    Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    PLoS One. 2017;12:e0175828.
    PubMed     Abstract available


  321. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Abstract available


  322. HO TW, Huang CT, Ruan SY, Tsai YJ, et al
    Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
    PLoS One. 2017;12:e0175794.
    PubMed     Abstract available


  323. LI JN, Jia X, Wang Y, Xie C, et al
    Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides.
    PLoS One. 2017;12:e0174553.
    PubMed     Abstract available


  324. HINTSA S, Dube L, Abay M, Angesom T, et al
    Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study.
    PLoS One. 2017;12:e0173566.
    PubMed     Abstract available


  325. KRAMER J, Tenberge JG, Kleiter I, Gaissmaier W, et al
    Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    PLoS One. 2017;12:e0174858.
    PubMed     Abstract available


  326. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Abstract available


  327. GUSTAFSSON JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, et al
    Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    PLoS One. 2017;12:e0174572.
    PubMed     Abstract available


  328. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Abstract available


  329. RAFFEL J, Gafson AR, Dahdaleh S, Malik O, et al
    Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.
    PLoS One. 2017;12:e0169546.
    PubMed     Abstract available


  330. ZITTEMA D, Casteleijn NF, Bakker SJ, Boesten LS, et al
    Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    PLoS One. 2017;12:e0169263.
    PubMed     Abstract available


  331. KAVALIUNAS A, Manouchehrinia A, Danylaite Karrenbauer V, Gyllensten H, et al
    Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
    PLoS One. 2017;12:e0169460.
    PubMed     Abstract available


  332. ATKILT HS, Turago MG, Tegegne BS
    Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169666.
    PubMed     Abstract available


  333. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Abstract available


  334. BONFIGLIO T, Olivero G, Merega E, Di Prisco S, et al
    Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2017;12:e0170825.
    PubMed     Abstract available


  335. YEUNG KS, Chung BH, Choufani S, Mok MY, et al
    Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
    PLoS One. 2017;12:e0169553.
    PubMed     Abstract available


  336. BYTOFT B, Knorr S, Vlachova Z, Jensen RB, et al
    Assessment of Attention Deficits in Adolescent Offspring Exposed to Maternal Type 1 Diabetes.
    PLoS One. 2017;12:e0169308.
    PubMed     Abstract available


  337. URRUTIA I, Martinez R, Lopez-Euba T, Velayos T, et al
    Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.
    PLoS One. 2017;12:e0169389.
    PubMed     Abstract available


  338. HERNANDEZ-MIR G, McGeachy MJ
    CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.
    PLoS One. 2017;12:e0173655.
    PubMed     Abstract available


  339. MISTERSKA E, Kaminiarczyk-Pyzalka D, Adamczak K, Adamczyk KA, et al
    Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire.
    PLoS One. 2017;12:e0173768.
    PubMed     Abstract available


  340. PAPOTTO PH, Marengo EB, Sardinha LR, Carvalho KI, et al
    Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-gamma production.
    PLoS One. 2017;12:e0171822.
    PubMed     Abstract available


  341. KOMEGAE EN, Souza TA, Grund LZ, Lima C, et al
    Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0171796.
    PubMed     Abstract available


  342. MUNROE ME, Pezant N, Brown MA, Fife DA, et al
    Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.
    PLoS One. 2017;12:e0171193.
    PubMed     Abstract available


  343. TOFFOLI B, Gilardi F, Winkler C, Soderberg M, et al
    Nephropathy in Pparg-null mice highlights PPARgamma systemic activities in metabolism and in the immune system.
    PLoS One. 2017;12:e0171474.
    PubMed     Abstract available


  344. ZOU L, Wang H, Xiao Z, Fang Q, et al
    Tai chi for health benefits in patients with multiple sclerosis: A systematic review.
    PLoS One. 2017;12:e0170212.
    PubMed     Abstract available


  345. NA W, Yi K, Song YS, Park MH, et al
    Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.
    PLoS One. 2017;12:e0174501.
    PubMed     Abstract available


  346. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Abstract available


  347. LUDVIGSSON J, Jones MP, Faresjo A
    Worm infestations and development of autoimmunity in children - The ABIS study.
    PLoS One. 2017;12:e0173988.
    PubMed     Abstract available


  348. CECCARELLI F, Sciandrone M, Perricone C, Galvan G, et al
    Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.
    PLoS One. 2017;12:e0174200.
    PubMed     Abstract available


  349. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Abstract available


  350. FAIZY TD, Thaler C, Ceyrowski T, Broocks G, et al
    Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.
    PLoS One. 2017;12:e0172923.
    PubMed     Abstract available


  351. MIZUNO M, Noto D, Kaga N, Chiba A, et al
    The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models.
    PLoS One. 2017;12:e0173032.
    PubMed     Abstract available


  352. BLOSS S, Klemann C, Rother AK, Mehmecke S, et al
    Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.
    PLoS One. 2017;12:e0172532.
    PubMed     Abstract available


  353. REGNELL SE, Hessner MJ, Jia S, Akesson L, et al
    Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats.
    PLoS One. 2017;12:e0171372.
    PubMed     Abstract available


  354. MOON Y, McGinnis RS, Seagers K, Motl RW, et al
    Monitoring gait in multiple sclerosis with novel wearable motion sensors.
    PLoS One. 2017;12:e0171346.
    PubMed     Abstract available


  355. NICHOLAS D, Proctor EA, Raval FM, Ip BC, et al
    Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis.
    PLoS One. 2017;12:e0170975.
    PubMed     Abstract available


  356. LINK J, Ramanujam R, Auer M, Ryner M, et al
    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
    PLoS One. 2017;12:e0170395.
    PubMed     Abstract available


  357. MARTINS CO, Demarchi L, Ferreira FM, Pomerantzeff PM, et al
    Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
    PLoS One. 2017;12:e0170191.
    PubMed     Abstract available


  358. DILLON MP, Fortington LV, Akram M, Erbas B, et al
    Geographic Variation of the Incidence Rate of Lower Limb Amputation in Australia from 2007-12.
    PLoS One. 2017;12:e0170705.
    PubMed     Abstract available


  359. ETCHEGARAY-MORALES I, Mendez-Martinez S, Jimenez-Hernandez C, Mendoza-Pinto C, et al
    Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.
    PLoS One. 2017;12:e0170209.
    PubMed     Abstract available


  360. UECKER FC, Olze H, Kunte H, Gerz C, et al
    Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis.
    PLoS One. 2017;12:e0170492.
    PubMed     Abstract available


  361. HURTADO-GUERRERO I, Pinto-Medel MJ, Urbaneja P, Rodriguez-Bada JL, et al
    Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNss in Multiple Sclerosis Patients According to the Therapeutic Response to IFNss.
    PLoS One. 2017;12:e0170031.
    PubMed     Abstract available


  362. TIMILSHINA M, Kang Y, Dahal I, You Z, et al
    BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression.
    PLoS One. 2017;12:e0168942.
    PubMed     Abstract available


  363. ELOI M, Horvath DV, Ortega JC, Prado MS, et al
    25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients.
    PLoS One. 2017;12:e0170323.
    PubMed     Abstract available


  364. LIBERTINOVA J, Meluzinova E, Tomek A, Horakova D, et al
    Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNbeta.
    PLoS One. 2017;12:e0169957.
    PubMed     Abstract available


  365. AZZI J, Thueson L, Moore R, Abdoli R, et al
    PI3Kgamma Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
    PLoS One. 2017;12:e0169695.
    PubMed     Abstract available


  366. FARIA BF, Mostardinha P, Vistulo de Abreu F
    Can the Immune System Perform a t-Test?
    PLoS One. 2017;12:e0169464.
    PubMed     Abstract available


  367. ESSIEN O, Otu A, Umoh V, Enang O, et al
    Intensive Patient Education Improves Glycaemic Control in Diabetes Compared to Conventional Education: A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital.
    PLoS One. 2017;12:e0168835.
    PubMed     Abstract available


  368. BROCHET B, Deloire MS, Perez P, Loock T, et al
    Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2017;12:e0168834.
    PubMed     Abstract available


  369. LAND J, Abdulahad WH, Arends S, Sanders JF, et al
    Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
    PLoS One. 2017;12:e0182549.
    PubMed     Abstract available


  370. VAN ESDONK MJ, Tai B, Cotterill A, Charles B, et al
    Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling.
    PLoS One. 2017;12:e0182181.
    PubMed     Abstract available


  371. WAUGH K, Snell-Bergeon J, Michels A, Dong F, et al
    Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
    PLoS One. 2017;12:e0174840.
    PubMed     Abstract available


  372. ZHAO Y, Healy BC, Rotstein D, Guttmann CR, et al
    Exploration of machine learning techniques in predicting multiple sclerosis disease course.
    PLoS One. 2017;12:e0174866.
    PubMed     Abstract available


  373. KIIRE CA, Horak K, Lee KE, Klein BE, et al
    The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study.
    PLoS One. 2017;12:e0174979.
    PubMed     Abstract available


  374. HEGEN H, Auer M, Bsteh G, Di Pauli F, et al
    Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.
    PLoS One. 2017;12:e0174005.
    PubMed     Abstract available


  375. XIA N, Ye X, Hu X, Song S, et al
    Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    PLoS One. 2017;12:e0174260.
    PubMed     Abstract available


  376. NICKERSON KM, Wang Y, Bastacky S, Shlomchik MJ, et al
    Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
    PLoS One. 2017;12:e0173471.
    PubMed     Abstract available


  377. LIMA PD, Chen Z, Tayab A, Murphy MS, et al
    Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.
    PLoS One. 2017;12:e0172988.
    PubMed     Abstract available


  378. WENDEBOURG MJ, Heesen C, Finlayson M, Meyer B, et al
    Patient education for people with multiple sclerosis-associated fatigue: A systematic review.
    PLoS One. 2017;12:e0173025.
    PubMed     Abstract available


  379. EUESDEN J, Danese A, Lewis CM, Maughan B, et al
    A bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development Study.
    PLoS One. 2017;12:e0173015.
    PubMed     Abstract available


  380. ONO N, Murakami K, Chan O, Hall H, et al
    Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes.
    PLoS One. 2017;12:e0173176.
    PubMed     Abstract available


  381. POURCINE F, Dahan K, Mihout F, Cachanado M, et al
    Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    PLoS One. 2017;12:e0173201.
    PubMed     Abstract available


  382. MORANDI E, Tanasescu R, Tarlinton RE, Constantinescu CS, et al
    The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172415.
    PubMed     Abstract available


  383. BEHBEHANI R, Abu Al-Hassan A, Al-Salahat A, Sriraman D, et al
    Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    PLoS One. 2017;12:e0172120.
    PubMed     Abstract available


  384. VAITAITIS GM, Yussman MG, Waid DM, Wagner DH Jr, et al
    Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    PLoS One. 2017;12:e0172037.
    PubMed     Abstract available


  385. HISA K, Yanagimachi MD, Naruto T, Miyamae T, et al
    PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
    PLoS One. 2017;12:e0171961.
    PubMed     Abstract available


  386. MOCCIA M, Palladino R, Lanzillo R, Carotenuto A, et al
    Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.
    PLoS One. 2017;12:e0169489.
    PubMed     Abstract available


  387. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Abstract available


  388. MAGNUSSON K, Bech Holte K, Juel NG, Brox JI, et al
    Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study.
    PLoS One. 2017;12:e0177118.
    PubMed     Abstract available


  389. LAM HV, Nguyen DT, Nguyen CD
    Sibling method increases risk assessment estimates for type 1 diabetes.
    PLoS One. 2017;12:e0176341.
    PubMed     Abstract available


  390. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Abstract available


  391. SCOTT A, Chambers D, Goyder E, O'Cathain A, et al
    Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review.
    PLoS One. 2017;12:e0177210.
    PubMed     Abstract available


  392. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Abstract available


  393. NIEGOWSKA M, Delitala A, Pes GM, Delitala G, et al
    Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.
    PLoS One. 2017;12:e0176584.
    PubMed     Abstract available


  394. MARINO KR, Lundberg RL, Jasrotia A, Maranda LS, et al
    A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    PLoS One. 2017;12:e0176860.
    PubMed     Abstract available


  395. IZQUIERDO G, Damas F, Paramo MD, Ruiz-Pena JL, et al
    The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.
    PLoS One. 2017;12:e0176174.
    PubMed     Abstract available


  396. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Abstract available


  397. SCHNEIDER R, Bellenberg B, Hoepner R, Kolb EM, et al
    Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    PLoS One. 2017;12:e0176415.
    PubMed     Abstract available


  398. ZHAN Z, Yang Y, Zhan Y, Chen D, et al
    Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.
    PLoS One. 2017;12:e0176457.
    PubMed     Abstract available


  399. INGLESE M, Petracca M, Mormina E, Achiron A, et al
    Cerebellar volume as imaging outcome in progressive multiple sclerosis.
    PLoS One. 2017;12:e0176519.
    PubMed     Abstract available


  400. QIAO YC, Chen YL, Pan YH, Tian F, et al
    The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176157.
    PubMed     Abstract available


  401. TALMAGE GD, Coppes OJM, Javed A, Bernard J, et al
    Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.
    PLoS One. 2017;12:e0173299.
    PubMed     Abstract available


  402. HARRIS VK, Bell L, Langan RA, Tuddenham J, et al
    Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
    PLoS One. 2017;12:e0175575.
    PubMed     Abstract available


  403. GIESS RM, Pfuhl C, Behrens JR, Rasche L, et al
    Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    PLoS One. 2017;12:e0175279.
    PubMed     Abstract available


  404. DOBRAKOWSKI P, Bogocz M, Cholewa K, Rajchel M, et al
    Month of birth and level of insolation as risk factors for multiple sclerosis in Poland.
    PLoS One. 2017;12:e0175156.
    PubMed     Abstract available


  405. HANAOKA H, Kiyokawa T, Iida H, Ishimori K, et al
    Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
    PLoS One. 2017;12:e0175152.
    PubMed     Abstract available


  406. LLAURADO G, Cano A, Hernandez C, Gonzalez-Sastre M, et al
    Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.
    PLoS One. 2017;12:e0174640.
    PubMed     Abstract available


  407. YAN T, Ke Y, Chen Y, Xu C, et al
    Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    PLoS One. 2017;12:e0174735.
    PubMed     Abstract available


  408. AYUSO T, Aznar P, Soriano L, Olaskoaga A, et al
    Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    PLoS One. 2017;12:e0174726.
    PubMed     Abstract available


  409. NEEDELL JC, Dinarello CA, Ir D, Robertson CE, et al
    Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    PLoS One. 2017;12:e0173968.
    PubMed     Abstract available


  410. MULS N, Nasr Z, Dang HA, Sindic C, et al
    IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.
    PLoS One. 2017;12:e0173780.
    PubMed     Abstract available


  411. HIROOKA K, Saito W, Namba K, Mizuuchi K, et al
    Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
    PLoS One. 2017;12:e0172612.
    PubMed     Abstract available


  412. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Abstract available


  413. RAGHAV A, Ahmad J, Alam K
    Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    PLoS One. 2017;12:e0176970.
    PubMed     Abstract available


  414. TAKEUCHI Y, Saito A, Ojima Y, Kagaya S, et al
    The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study.
    PLoS One. 2017;12:e0177482.
    PubMed     Abstract available


  415. MOLINA-JIJON E, Rodriguez-Munoz R, Gonzalez-Ramirez R, Namorado-Tonix C, et al
    Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
    PLoS One. 2017;12:e0177362.
    PubMed     Abstract available


  416. CHARVET LE, Yang J, Shaw MT, Sherman K, et al
    Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    PLoS One. 2017;12:e0177177.
    PubMed     Abstract available


  417. BOUGNERES P, Le Fur S, Valtat S, Kamatani Y, et al
    Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis.
    PLoS One. 2017;12:e0170658.
    PubMed     Abstract available


  418. TSAI FJ, Chen SY, Liu YC, Liao HY, et al
    The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice.
    PLoS One. 2017;12:e0181423.
    PubMed     Abstract available


  419. YUN JS, Bae JM, Kim KJ, Jung YS, et al
    Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea.
    PLoS One. 2017;12:e0179088.
    PubMed     Abstract available


  420. PARDO E, Carcamo C, Uribe-San Martin R, Ciampi E, et al
    Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    PLoS One. 2017;12:e0177472.
    PubMed     Abstract available


  421. LUNDBERG M, Lindqvist A, Wierup N, Krogvold L, et al
    The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes.
    PLoS One. 2017;12:e0179911.
    PubMed     Abstract available


  422. TAUBERT R, Hardtke-Wolenski M, Noyan F, Lalanne C, et al
    Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.
    PLoS One. 2017;12:e0179074.
    PubMed     Abstract available


  423. PAUZUOLIS M, Eich T, Burman J
    Quantification of gammadelta T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.
    PLoS One. 2017;12:e0179095.
    PubMed     Abstract available


  424. CHAMI M, Halmer R, Schnoeder L, Anne Becker K, et al
    Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
    PLoS One. 2017;12:e0178622.
    PubMed     Abstract available


  425. GUARDIA-OLMOS J, Gallardo-Moreno GB, Gudayol-Ferre E, Pero-Cebollero M, et al
    Effect of verbal task complexity in a working memory paradigm in patients with type 1 diabetes. A fMRI study.
    PLoS One. 2017;12:e0178172.
    PubMed     Abstract available


  426. MIYAWAKI Y, Katsuyama T, Sada KE, Hiramatsu S, et al
    A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.
    PLoS One. 2017;12:e0178018.
    PubMed     Abstract available


  427. PARK JY, Yang HK, Hwang JM
    Diagnostic value of repeated ice tests in the evaluation of ptosis in myasthenia gravis.
    PLoS One. 2017;12:e0177078.
    PubMed     Abstract available


  428. LU G, Zhang X, Shen L, Qiao Q, et al
    CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy.
    PLoS One. 2017;12:e0178352.
    PubMed     Abstract available


  429. GUO R, Zhou Y, Lu L, Cao L, et al
    Atopy in children with juvenile systemic lupus erythematosus is associated with severe disease.
    PLoS One. 2017;12:e0177774.
    PubMed     Abstract available


  430. SEOK JM, Choi M, Cho EB, Lee HL, et al
    Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.
    PLoS One. 2017;12:e0177230.
    PubMed     Abstract available


  431. NISHIKAI-YAN SHEN T, Kanazawa S, Kado M, Okada K, et al
    Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice.
    PLoS One. 2017;12:e0178232.
    PubMed     Abstract available


  432. MOLLISON D, Sellar R, Bastin M, Mollison D, et al
    The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0177727.
    PubMed     Abstract available


  433. ALSOP J, Medin J, Cornelissen C, Vormfelde SV, et al
    Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.
    PLoS One. 2017;12:e0173353.
    PubMed     Abstract available


  434. TONGYOO P, Avihingsanon Y, Prom-On S, Mutirangura A, et al
    EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes.
    PLoS One. 2017;12:e0177119.
    PubMed     Abstract available


  435. IP FCF, Ng YP, Or TCT, Sun P, et al
    Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.
    PLoS One. 2017;12:e0182069.
    PubMed     Abstract available


  436. BSTEH G, Ehling R, Walchhofer LM, Hegen H, et al
    Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.
    PLoS One. 2017;12:e0181458.
    PubMed     Abstract available


  437. GARCIA TS, Rech TH, Leitao CB
    Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies.
    PLoS One. 2017;12:e0180911.
    PubMed     Abstract available


  438. BERNITSAS E, Khan O, Razmjou S, Tselis A, et al
    Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.
    PLoS One. 2017;12:e0181431.
    PubMed     Abstract available


  439. TORTOSA C, Cabrera-Marante O, Serrano M, Martinez-Flores JA, et al
    Incidence of thromboembolic events in asymptomatic carriers of IgA anti ss2 glycoprotein-I antibodies.
    PLoS One. 2017;12:e0178889.
    PubMed     Abstract available


  440. LEISS H, Salzberger W, Jacobs B, Gessl I, et al
    MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.
    PLoS One. 2017;12:e0181015.
    PubMed     Abstract available


  441. DIESTELHORST J, Junge N, Schlue J, Falk CS, et al
    Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    PLoS One. 2017;12:e0181107.
    PubMed     Abstract available


  442. REIMER A, Schmitt A, Ehrmann D, Kulzer B, et al
    Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study.
    PLoS One. 2017;12:e0181218.
    PubMed     Abstract available


  443. HAUPT-JORGENSEN M, Nielsen E, Engkilde K, Lerche M, et al
    Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study.
    PLoS One. 2017;12:e0181143.
    PubMed     Abstract available


  444. WHEELOCK KM, Cai J, Looker HC, Merchant ML, et al
    Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    PLoS One. 2017;12:e0180964.
    PubMed     Abstract available


  445. SILVA SL, Albuquerque A, Amaral AJ, Li QZ, et al
    Autoimmunity and allergy control in adults submitted to complete thymectomy early in infancy.
    PLoS One. 2017;12:e0180385.
    PubMed     Abstract available


  446. RIGHART R, Schmidt P, Dahnke R, Biberacher V, et al
    Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients.
    PLoS One. 2017;12:e0179590.
    PubMed     Abstract available


  447. TAKAHASHI H, Nishimura R, Onda Y, Ando K, et al
    Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.
    PLoS One. 2017;12:e0177283.
    PubMed     Abstract available


  448. TOVOTE KA, Schroevers MJ, Snippe E, Emmelkamp PMG, et al
    What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes.
    PLoS One. 2017;12:e0179941.
    PubMed     Abstract available


  449. ROBERTS FR, Hupple C, Norowski E, Walsh NC, et al
    Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model.
    PLoS One. 2017;12:e0178641.
    PubMed     Abstract available


  450. SATO K, Nishijima T, Yokokawa T, Fujita S, et al
    Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes.
    PLoS One. 2017;12:e0178505.
    PubMed     Abstract available


  451. MCGINNIS RS, Mahadevan N, Moon Y, Seagers K, et al
    A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.
    PLoS One. 2017;12:e0178366.
    PubMed     Abstract available


  452. NYALWIDHE JO, Grzesik WJ, Burch TC, Semeraro ML, et al
    Comparative quantitative proteomic analysis of disease stratified laser captured microdissected human islets identifies proteins and pathways potentially related to type 1 diabetes.
    PLoS One. 2017;12:e0183908.
    PubMed     Abstract available


  453. GRANADOS HM, Draghi A 2nd, Tsurutani N, Wright K, et al
    Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes.
    PLoS One. 2017;12:e0183887.
    PubMed     Abstract available


  454. THALER C, Schneider T, Sedlacik J, Kutzner D, et al
    T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis.
    PLoS One. 2017;12:e0183099.
    PubMed     Abstract available


  455. MOROSO A, Ruet A, Lamargue-Hamel D, Munsch F, et al
    Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
    PLoS One. 2017;12:e0182479.
    PubMed     Abstract available


  456. TAKAYASU L, Suda W, Watanabe E, Fukuda S, et al
    A 3-dimensional mathematical model of microbial proliferation that generates the characteristic cumulative relative abundance distributions in gut microbiomes.
    PLoS One. 2017;12:e0180863.
    PubMed     Abstract available


  457. VILLANI M, Nanayakkara N, Ranasinha S, Earnest A, et al
    Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study.
    PLoS One. 2017;12:e0182413.
    PubMed     Abstract available


  458. DE RIVA A, Wallberg M, Ronchi F, Coulson R, et al
    Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.
    PLoS One. 2017;12:e0181964.
    PubMed     Abstract available


  459. MIRET M, Horvath-Puho E, Deruaz-Luyet A, Sorensen HT, et al
    Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
    PLoS One. 2017;12:e0181564.
    PubMed     Abstract available


  460. LEE KY, Yoo BW, Ahn SS, Bae WH, et al
    Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.
    PLoS One. 2017;12:e0181590.
    PubMed     Abstract available


  461. LANDI D, Albanese M, Buttari F, Monteleone F, et al
    Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study.
    PLoS One. 2017;12:e0165415.
    PubMed     Abstract available


  462. REVEIZ L, Haby MM, Martinez-Vega R, Pinzon-Flores CE, et al
    Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols.
    PLoS One. 2017;12:e0180220.
    PubMed     Abstract available


  463. NEGI S, Singh H, Mukhopadhyay A
    Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study.
    PLoS One. 2017;12:e0180518.
    PubMed     Abstract available


  464. CHANG YW, Chou YC, Yeh CC, Hu CJ, et al
    Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study.
    PLoS One. 2017;12:e0180433.
    PubMed     Abstract available


  465. JONAS SF, Mbogning C, Hassler S, Broet P, et al
    A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.
    PLoS One. 2017;12:e0179896.
    PubMed     Abstract available


  466. CHARALAMPOPOULOS D, Hesketh KR, Amin R, Paes VM, et al
    Psycho-educational interventions for children and young people with Type 1 Diabetes in the UK: How effective are they? A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179685.
    PubMed     Abstract available


  467. TANG KT, Hsieh TY, Chao YH, Lin MX, et al
    Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
    PLoS One. 2017;12:e0178404.
    PubMed     Abstract available


  468. EBBO M, Grados A, Samson M, Groh M, et al
    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
    PLoS One. 2017;12:e0183844.
    PubMed     Abstract available


  469. REN S, Wang Y, Xian L, Toyama T, et al
    Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    PLoS One. 2017;12:e0184398.
    PubMed     Abstract available


  470. WURTH S, Kuenz B, Bsteh G, Ehling R, et al
    Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    PLoS One. 2017;12:e0182462.
    PubMed     Abstract available


  471. LIN TS, Hsu PY, Chang CH, Ko CL, et al
    Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.
    PLoS One. 2017;12:e0182344.
    PubMed     Abstract available


  472. MESSINA S, Solaro C, Righini I, Bergamaschi R, et al
    Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
    PLoS One. 2017;12:e0180651.
    PubMed     Abstract available


  473. KARAMPETSOU MP, Comte D, Kis-Toth K, Kyttaris VC, et al
    Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.
    PLoS One. 2017;12:e0186073.
    PubMed     Abstract available


  474. MARITATI F, Alberici F, Oliva E, Urban ML, et al
    Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    PLoS One. 2017;12:e0185880.
    PubMed     Abstract available


  475. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    PubMed     Abstract available


  476. KISO K, Yoshifuji H, Oku T, Hikida M, et al
    Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.
    PLoS One. 2017;12:e0184738.
    PubMed     Abstract available


  477. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Abstract available


  478. DIAZ-RIZO V, Bonilla-Lara D, Gonzalez-Lopez L, Sanchez-Mosco D, et al
    Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis.
    PLoS One. 2017;12:e0184056.
    PubMed     Abstract available


  479. NEEDELL JC, Ir D, Robertson CE, Kroehl ME, et al
    Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring.
    PLoS One. 2017;12:e0183786.
    PubMed     Abstract available


  480. MAULUCCI G, Cordelli E, Rizzi A, De Leva F, et al
    Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    PLoS One. 2017;12:e0184109.
    PubMed     Abstract available


  481. MANUWALD U, Heinke P, Salzsieder E, Hegewald J, et al
    Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany.
    PLoS One. 2017;12:e0183665.
    PubMed     Abstract available


  482. PUTHENPARAMPIL M, Federle L, Poggiali D, Miante S, et al
    Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
    PLoS One. 2017;12:e0183957.
    PubMed     Abstract available


  483. BLAZER A, Wang B, Simpson D, Kirchhoff T, et al
    Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
    PLoS One. 2017;12:e0182483.
    PubMed     Abstract available


  484. CEUNINCK VAN CAPELLE A, Meide HV, Vosman FJH, Visser LH, et al
    A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS).
    PLoS One. 2017;12:e0182806.
    PubMed     Abstract available


  485. ABDELHAK A, Hottenrott T, Mayer C, Hintereder G, et al
    CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
    PLoS One. 2017;12:e0182647.
    PubMed     Abstract available


  486. MODICA CM, Schweser F, Sudyn ML, Bertolino N, et al
    Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0182729.
    PubMed     Abstract available


  487. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Abstract available


  488. SONG F, Qian Y, Peng X, Li X, et al
    The frontline of immune response in peripheral blood.
    PLoS One. 2017;12:e0182294.
    PubMed     Abstract available


  489. WASHBURN N, Meccariello R, Hu S, Hains M, et al
    High-resolution physicochemical characterization of different intravenous immunoglobulin products.
    PLoS One. 2017;12:e0181251.
    PubMed     Abstract available


  490. SILVA-VILCHES C, Pletinckx K, Lohnert M, Pavlovic V, et al
    Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.
    PLoS One. 2017;12:e0178114.
    PubMed     Abstract available


  491. KIDD T, Carey N, Mold F, Westwood S, et al
    A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life.
    PLoS One. 2017;12:e0185931.
    PubMed     Abstract available


  492. HU WS, Rajendran P, Tzang BS, Yeh YL, et al
    Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.
    PLoS One. 2017;12:e0185098.
    PubMed     Abstract available


  493. KIM HH, Jeong IH, Hyun JS, Kong BS, et al
    Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
    PLoS One. 2017;12:e0181758.
    PubMed     Abstract available


  494. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Abstract available


  495. FAVARETTO A, Lazzarotto A, Riccardi A, Pravato S, et al
    Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis.
    PLoS One. 2017;12:e0185626.
    PubMed     Abstract available


  496. MAKINO T, Nakamura R, Terakawa M, Muneoka S, et al
    Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.
    PLoS One. 2017;12:e0185976.
    PubMed     Abstract available


  497. LUO W, Zhou B, Luo Q, Fang H, et al
    Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population.
    PLoS One. 2017;12:e0186409.
    PubMed     Abstract available


  498. PERROTTI PP, Aterido A, Fernandez-Nebro A, Canete JD, et al
    Genetic variation associated with cardiovascular risk in autoimmune diseases.
    PLoS One. 2017;12:e0185889.
    PubMed     Abstract available


  499. MIETTINEN ME, Smart MC, Kinnunen L, Harjutsalo V, et al
    Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.
    PLoS One. 2017;12:e0184942.
    PubMed     Abstract available


  500. KURIAN SM, Ferreri K, Wang CH, Todorov I, et al
    Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice.
    PLoS One. 2017;12:e0185331.
    PubMed     Abstract available


  501. LIN JD, Yang SF, Wang YH, Fang WF, et al
    Associations of melatonin receptor gene polymorphisms with Graves' disease.
    PLoS One. 2017;12:e0185529.
    PubMed     Abstract available


  502. BERGGREN O, Hagberg N, Alexsson A, Weber G, et al
    Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype.
    PLoS One. 2017;12:e0183946.
    PubMed     Abstract available


  503. MASUDA H, Hirano S, Takahashi N, Hatsugano E, et al
    Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
    PLoS One. 2017;12:e0184012.
    PubMed     Abstract available


  504. RAIMONDO MG, Pericleous C, Radziszewska A, Borghi MO, et al
    Oxidation of beta2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
    PLoS One. 2017;12:e0186513.
    PubMed     Abstract available


  505. FERNANDEZ O, Duran E, Ayuso T, Hernandez L, et al
    Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study).
    PLoS One. 2017;12:e0185766.
    PubMed     Abstract available


  506. ASANO T, Ito H, Kariya Y, Hoshi K, et al
    Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
    PLoS One. 2017;12:e0186414.
    PubMed     Abstract available


  507. POPPERUD TH, Viken MK, Kerty E, Lie BA, et al
    Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.
    PLoS One. 2017;12:e0186383.
    PubMed     Abstract available


  508. BESELER C, Vollmer T, Graner M, Yu X, et al
    The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    PLoS One. 2017;12:e0186842.
    PubMed     Abstract available


  509. GUSTAFSSON P, Crenshaw AG, Edmundsson D, Toolanen G, et al
    Muscle oxygenation in Type 1 diabetic and non-diabetic patients with and without chronic compartment syndrome.
    PLoS One. 2017;12:e0186790.
    PubMed     Abstract available


  510. WU YD, Lin CH, Chao WC, Liao TL, et al
    Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study.
    PLoS One. 2017;12:e0187075.
    PubMed     Abstract available


  511. GOLEBIEWSKA J, Olechowski A, Wysocka-Mincewicz M, Odrobina D, et al
    Optical coherence tomography angiography vessel density in children with type 1 diabetes.
    PLoS One. 2017;12:e0186479.
    PubMed     Abstract available


  512. KENDRICK SK, Zheng Q, Garbett NC, Brock GN, et al
    Application and interpretation of functional data analysis techniques to differential scanning calorimetry data from lupus patients.
    PLoS One. 2017;12:e0186232.
    PubMed     Abstract available


  513. AL HARIRI M, Elmedawar M, Zhu R, Jaffa MA, et al
    Proteome profiling in the aorta and kidney of type 1 diabetic rats.
    PLoS One. 2017;12:e0187752.
    PubMed     Abstract available


  514. MARGIOTTA DPE, Basta F, Dolcini G, Batani V, et al
    The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus.
    PLoS One. 2017;12:e0187645.
    PubMed     Abstract available


  515. CONTRERAS I, Oviedo S, Vettoretti M, Visentin R, et al
    Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models.
    PLoS One. 2017;12:e0187754.
    PubMed     Abstract available


  516. HONORAT JA, Nakatsuji Y, Shimizu M, Kinoshita M, et al
    Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner.
    PLoS One. 2017;12:e0187215.
    PubMed     Abstract available


  517. RAKNES G, Smabrekke L
    Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study.
    PLoS One. 2017;12:e0187423.
    PubMed     Abstract available


  518. INAGAKI K, Yasuda Y, Ando M, Kaihan AB, et al
    Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission.
    PLoS One. 2017;12:e0187607.
    PubMed     Abstract available


  519. OKA S, Furukawa H, Yasunami M, Kawasaki A, et al
    HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
    PLoS One. 2017;12:e0187325.
    PubMed     Abstract available


  520. ESTEVE C, Samson M, Guilhem A, Nicolas B, et al
    Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
    PLoS One. 2017;12:e0187296.
    PubMed     Abstract available


  521. HOUSHMAND-OEREGAARD A, Hjort L, Kelstrup L, Hansen NS, et al
    DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy.
    PLoS One. 2017;12:e0187038.
    PubMed     Abstract available


  522. LIN SJ, Kuo ML, Hsiao HS, Lee PT, et al
    Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.
    PLoS One. 2017;12:e0186223.
    PubMed     Abstract available


  523. CHOI JY, Jung JH, Shin S, Kim YH, et al
    Association between the pancreas transplantation and survival of patients with diabetes: A single center experience.
    PLoS One. 2017;12:e0186827.
    PubMed     Abstract available


  524. AL-RUBEAAN K, Almashouq MK, Youssef AM, Al-Qumaidi H, et al
    All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia.
    PLoS One. 2017;12:e0188097.
    PubMed     Abstract available


  525. MOISSET X, Perie M, Pereira B, Dumont E, et al
    Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study.
    PLoS One. 2017;12:e0188120.
    PubMed     Abstract available


  526. MIYAZAWA M, Takatori H, Shimakami T, Kawaguchi K, et al
    Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    PLoS One. 2017;12:e0188549.
    PubMed     Abstract available


  527. NAVARRO-QUIROZ E, Pacheco-Lugo L, Navarro-Quiroz R, Lorenzi H, et al
    Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
    PLoS One. 2017;12:e0187973.
    PubMed     Abstract available


  528. DUNHAM J, van de Vis R, Bauer J, Wubben J, et al
    Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey.
    PLoS One. 2017;12:e0188013.
    PubMed     Abstract available


  529. WEN J, Yablonskiy DA, Salter A, Cross AH, et al
    Limbic system damage in MS: MRI assessment and correlations with clinical testing.
    PLoS One. 2017;12:e0187915.
    PubMed     Abstract available


  530. LADFORS L, Shaat N, Wiberg N, Katasarou A, et al
    Fetal overgrowth in women with type 1 and type 2 diabetes mellitus.
    PLoS One. 2017;12:e0187917.
    PubMed     Abstract available


  531. KORF H, Breser L, Van Hoeck J, Godoy J, et al
    MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.
    PLoS One. 2017;12:e0187455.
    PubMed     Abstract available


  532. DE GROOT PF, Belzer C, Aydin O, Levin E, et al
    Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study.
    PLoS One. 2017;12:e0188475.
    PubMed     Abstract available


  533. JONES IV AR, Coleman EL, Husni NR, Deeney JT, et al
    Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.
    PLoS One. 2017;12:e0188474.
    PubMed     Abstract available


  534. TANG X, Zhao S, Chiu APY, Wang X, et al
    Analysing increasing trends of Guillain-Barre Syndrome (GBS) and dengue cases in Hong Kong using meteorological data.
    PLoS One. 2017;12:e0187830.
    PubMed     Abstract available


  535. HORVEI KD, Pedersen HL, Fismen S, Thiyagarajan D, et al
    Lupus nephritis progression in FcgammaRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.
    PLoS One. 2017;12:e0188863.
    PubMed     Abstract available


  536. PARKKOLA A, Laine AP, Karhunen M, Harkonen T, et al
    HLA and non-HLA genes and familial predisposition to autoimmune diseases in families with a child affected by type 1 diabetes.
    PLoS One. 2017;12:e0188402.
    PubMed     Abstract available


  537. LIU S, Liu X, Chen S, Xiao Y, et al
    Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0188644.
    PubMed     Abstract available


  538. YU MY, Kim YC, Koo HS, Chin HJ, et al
    Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    PLoS One. 2017;12:e0188375.
    PubMed     Abstract available


  539. DOUBLIER S, Zennaro C, Musante L, Spatola T, et al
    Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    PLoS One. 2017;12:e0188045.
    PubMed     Abstract available


  540. GARBETT NC, Brock GN, Chaires JB, Mekmaysy CS, et al
    Characterization and classification of lupus patients based on plasma thermograms.
    PLoS One. 2017;12:e0186398.
    PubMed     Abstract available


  541. WYBRECHT D, Reuter F, Pariollaud F, Zaaraoui W, et al
    New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
    PLoS One. 2017;12:e0184650.
    PubMed     Abstract available


  542. IRACE C, Messiniti V, Tassone B, Cortese C, et al
    Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes.
    PLoS One. 2017;12:e0187525.
    PubMed     Abstract available


  543. GROBELNY A, Behrens JR, Mertens S, Otte K, et al
    Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    PLoS One. 2017;12:e0189281.
    PubMed     Abstract available


  544. PERRI V, Gianchecchi E, Cifaldi L, Pellegrino M, et al
    Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.
    PLoS One. 2017;12:e0189615.
    PubMed     Abstract available


  545. GREENFIELD J, Hudson M, Vinet E, Fortin PR, et al
    A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).
    PLoS One. 2017;12:e0189840.
    PubMed     Abstract available


  546. CHEN Y, Zhen W, Guo T, Zhao Y, et al
    Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
    PLoS One. 2017;12:e0189380.
    PubMed     Abstract available


  547. SASIDHAR MV, Chevooru SK, Eickelberg O, Hartung HP, et al
    Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    PLoS One. 2017;12:e0189701.
    PubMed     Abstract available


    January 2016
  548. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Abstract available


  549. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Abstract available


  550. MAGGI L, Margheri F, Luciani C, Capone M, et al
    Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.
    PLoS One. 2016;11:e0154422.
    PubMed     Abstract available


  551. RAMONDT S, Tiemensma J, Cameron LD, Broadbent E, et al
    Drawings of Blood Cells Reveal People's Perception of Their Blood Disorder: A Pilot Study.
    PLoS One. 2016;11:e0154348.
    PubMed     Abstract available


  552. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Abstract available


  553. HAASNOOT AJ, Vernie LA, Rothova A, V D Doe P, et al
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016;11:e0164312.
    PubMed     Abstract available


  554. KAUSHIK DK, Yong HY, Hahn JN, Silva C, et al
    Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
    PLoS One. 2016;11:e0163802.
    PubMed     Abstract available


  555. KALRON A, Givon U, Frid L, Dolev M, et al
    Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
    PLoS One. 2016;11:e0164467.
    PubMed     Abstract available


  556. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    PubMed     Abstract available


  557. RIEMANN-LORENZ K, Eilers M, von Geldern G, Schulz KH, et al
    Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.
    PLoS One. 2016;11:e0165246.
    PubMed     Abstract available


  558. MANICARDI V, Russo G, Napoli A, Torlone E, et al
    Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative.
    PLoS One. 2016;11:e0162960.
    PubMed     Abstract available


  559. JERNAS L, Wencel J, Wiak A, Bieniek M, et al
    Risk Factors for Poor Adherence to Betaferon(R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome.
    PLoS One. 2016;11:e0157950.
    PubMed     Abstract available


  560. OKANO J, Kojima H, Katagi M, Nakagawa T, et al
    Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.
    PLoS One. 2016;11:e0166215.
    PubMed     Abstract available


  561. DOBSON R, Ramagopalan S, Topping J, Smith P, et al
    A Risk Score for Predicting Multiple Sclerosis.
    PLoS One. 2016;11:e0164992.
    PubMed     Abstract available


  562. PROSPERINI L, de Rossi N, Scarpazza C, Moiola L, et al
    Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    PLoS One. 2016;11:e0168376.
    PubMed     Abstract available


  563. JOHNSON TW, Wu Y, Nathoo N, Rogers JA, et al
    Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0167196.
    PubMed     Abstract available


  564. VAN DALEM A, Demeester S, Balti EV, Keymeulen B, et al
    Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    PLoS One. 2016;11:e0166702.
    PubMed     Abstract available


  565. CHATTERJEE S, Bhardwaj N, Saxena RK
    Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.
    PLoS One. 2016;11:e0166878.
    PubMed     Abstract available


  566. MARTIN P, McGovern A, Massey J, Schoenfelder S, et al
    Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C.
    PLoS One. 2016;11:e0166923.
    PubMed     Abstract available


  567. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Abstract available


  568. RYDEN A, Sorstadius E, Bergenheim K, Romanovschi A, et al
    The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
    PLoS One. 2016;11:e0164977.
    PubMed     Abstract available


  569. KREMER IE, Evers SM, Jongen PJ, van der Weijden T, et al
    Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling.
    PLoS One. 2016;11:e0164862.
    PubMed     Abstract available


  570. BACHELET D, Hassler S, Mbogning C, Link J, et al
    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
    PLoS One. 2016;11:e0162752.
    PubMed     Abstract available


  571. ALROUGHANI R, Akhtar S, Ahmed S, Behbehani R, et al
    Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    PLoS One. 2016;11:e0165846.
    PubMed     Abstract available


  572. WANG X, Liu W, O'Donnell M, Lutgendorf S, et al
    Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    PLoS One. 2016;11:e0168772.
    PubMed     Abstract available


  573. PIVOT D, Debouverie M, Grzebyk M, Brassat D, et al
    Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    PLoS One. 2016;11:e0167556.
    PubMed     Abstract available


  574. MURIS AH, Smolders J, Rolf L, Klinkenberg LJ, et al
    Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
    PLoS One. 2016;11:e0156122.
    PubMed     Abstract available


  575. STAMILE C, Kocevar G, Cotton F, Durand-Dubief F, et al
    A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
    PLoS One. 2016;11:e0156405.
    PubMed     Abstract available


  576. DORONIN VB, Parkhomenko TA, Castellazzi M, Cesnik E, et al
    Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0154688.
    PubMed     Abstract available


  577. YASUI J, Kawasaki E, Tanaka S, Awata T, et al
    Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    PLoS One. 2016;11:e0155643.
    PubMed     Abstract available


  578. CHEN HH, Lin IC, Chen HJ, Yeh SY, et al
    Association of Herpes Zoster and Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0155175.
    PubMed     Abstract available


  579. LAIBLE M, Jarius S, Mackensen F, Schmidt-Bacher A, et al
    Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0155322.
    PubMed     Abstract available


  580. BEGGS CB, Magnano C, Belov P, Krawiecki J, et al
    Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0153960.
    PubMed     Abstract available


  581. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Abstract available


  582. LAMPRIANOU S, Gysemans C, Bou Saab J, Pontes H, et al
    Glibenclamide Prevents Diabetes in NOD Mice.
    PLoS One. 2016;11:e0168839.
    PubMed     Abstract available


  583. SALEHI Z, Doosti R, Beheshti M, Janzamin E, et al
    Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
    PLoS One. 2016;11:e0159565.
    PubMed     Abstract available


  584. BSTEH G, Ehling R, Lutterotti A, Hegen H, et al
    Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
    PLoS One. 2016;11:e0158978.
    PubMed     Abstract available


  585. VIROSTKO J, Hilmes M, Eitel K, Moore DJ, et al
    Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
    PLoS One. 2016;11:e0158825.
    PubMed     Abstract available


  586. LUIPPOLD G, Bedenik J, Voigt A, Grempler R, et al
    Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    PLoS One. 2016;11:e0156346.
    PubMed     Abstract available


  587. KARAMYAN A, Dunser MW, Wiebe DJ, Pilz G, et al
    Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
    PLoS One. 2016;11:e0155795.
    PubMed     Abstract available


  588. JELINEK GA, De Livera AM, Marck CH, Brown CR, et al
    Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
    PLoS One. 2016;11:e0161701.
    PubMed     Abstract available


  589. BINZ N, Rakoczy EP, Ali Rahman IS, Vagaja NN, et al
    Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
    PLoS One. 2016;11:e0160442.
    PubMed     Abstract available


  590. ABURAWI EH, AlKaabi J, Zoubeidi T, Shehab A, et al
    Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    PLoS One. 2016;11:e0159808.
    PubMed     Abstract available


  591. DARABIAN S, Backlund JY, Cleary PA, Sheidaee N, et al
    Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study.
    PLoS One. 2016;11:e0159958.
    PubMed     Abstract available


  592. DAVIES JL, Thompson S, Kaur-Sandhu H, Sawcer S, et al
    Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
    PLoS One. 2016;11:e0158327.
    PubMed     Abstract available


  593. DENNISON L, McCloy Smith E, Bradbury K, Galea I, et al
    How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
    PLoS One. 2016;11:e0158982.
    PubMed     Abstract available


  594. DAHL LC, Nasa Z, Chung J, Niego B, et al
    The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
    PLoS One. 2016;11:e0158653.
    PubMed     Abstract available


  595. ZHAO Z, Zou J, Zhao L, Cheng Y, et al
    Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
    PLoS One. 2016;11:e0157510.
    PubMed     Abstract available


  596. VALLERIE SN, Kramer F, Barnhart S, Kanter JE, et al
    Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.
    PLoS One. 2016;11:e0158316.
    PubMed     Abstract available


  597. SATUE M, Rodrigo MJ, Otin S, Bambo MP, et al
    Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0157293.
    PubMed     Abstract available


  598. QIN W, Liang YZ, Qin BY, Zhang JL, et al
    The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.
    PLoS One. 2016;11:e0156959.
    PubMed     Abstract available


  599. D'AMICO E, Leone C, Graziano G, Amato MP, et al
    The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
    PLoS One. 2016;11:e0157721.
    PubMed     Abstract available


  600. BOUDARHAM J, Hameau S, Zory R, Hardy A, et al
    Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0158267.
    PubMed     Abstract available


  601. PLAISTED WC, Zavala A, Hingco E, Tran H, et al
    Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0157620.
    PubMed     Abstract available


  602. RIQUELME MEDINA I, Lubovac-Pilav Z
    Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.
    PLoS One. 2016;11:e0156006.
    PubMed     Abstract available


  603. BUERTH C, Mausberg AK, Heininger MK, Hartung HP, et al
    Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
    PLoS One. 2016;11:e0155082.
    PubMed     Abstract available


  604. MASSA MG, Gisevius B, Hirschberg S, Hinz L, et al
    Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0155274.
    PubMed     Abstract available


  605. MCEWAN P, Bennett H, Fellows J, Priaulx J, et al
    The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162441.
    PubMed     Abstract available


  606. SOLARO C, Trabucco E, Signori A, Martinelli V, et al
    Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
    PLoS One. 2016;11:e0160261.
    PubMed     Abstract available


  607. SAVASTIO S, Cadario F, Genoni G, Bellomo G, et al
    Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162554.
    PubMed     Abstract available


  608. YANG Y, Ma YP, Chen DP, Zhuo L, et al
    A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    PLoS One. 2016;11:e0160437.
    PubMed     Abstract available


  609. BOHN B, Karges B, Vogel C, Otto KP, et al
    20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
    PLoS One. 2016;11:e0160971.
    PubMed     Abstract available


  610. FERNANDEZ O, Arroyo R, Martinez-Yelamos S, Marco M, et al
    Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart(R) Device in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0160313.
    PubMed     Abstract available


  611. GRACIEN RM, Jurcoane A, Wagner M, Reitz SC, et al
    The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0161036.
    PubMed     Abstract available


  612. HASEDA F, Imagawa A, Nishikawa H, Mitsui S, et al
    Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes.
    PLoS One. 2016;11:e0160576.
    PubMed     Abstract available


  613. IANNETTA M, Zingaropoli MA, Bellizzi A, Morreale M, et al
    Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
    PLoS One. 2016;11:e0160277.
    PubMed     Abstract available


  614. GILLI F, Chen X, Pachner AR, Gimi B, et al
    High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0160071.
    PubMed     Abstract available


  615. MARTIN JE, Raffel J, Nicholas R
    Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care.
    PLoS One. 2016;11:e0159210.
    PubMed     Abstract available


  616. DASKALAKI E, Diem P, Mougiakakou SG
    Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.
    PLoS One. 2016;11:e0158722.
    PubMed     Abstract available


  617. ERNSTSSON O, Gyllensten H, Alexanderson K, Tinghog P, et al
    Cost of Illness of Multiple Sclerosis - A Systematic Review.
    PLoS One. 2016;11:e0159129.
    PubMed     Abstract available


  618. AKAMATSU M, Makino N, Ikeda Y, Matsuda A, et al
    Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    PLoS One. 2016;11:e0158669.
    PubMed     Abstract available


  619. OBERT D, Helms G, Sattler MB, Jung K, et al
    Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
    PLoS One. 2016;11:e0162583.
    PubMed     Abstract available


  620. CLAUSEN TD, Bergholt T, Bouaziz O, Arpi M, et al
    Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study.
    PLoS One. 2016;11:e0161654.
    PubMed     Abstract available


  621. FATIMA N, Faisal SM, Zubair S, Ajmal M, et al
    Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects.
    PLoS One. 2016;11:e0161548.
    PubMed     Abstract available


  622. MURAKAMI T, Uji A, Suzuma K, Dodo Y, et al
    In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography.
    PLoS One. 2016;11:e0160317.
    PubMed     Abstract available


  623. PAOLICELLI D, Iannazzo S, Santoni L, Iaffaldano A, et al
    The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
    PLoS One. 2016;11:e0159214.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: